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Background:  Fish consumption is inversely associated with coronary heart disease (CHD), 
possibly due to the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA).  Dietary mercury from fish has been hypothesized to increase the risk of CHD. 
Objective and Design:  Test the relationships between fish FFQ/30 days and 24-hour 
DHA+EPA intakes and CHD risk markers (high density lipoprotein (HDL), low density 
lipoprotein, total cholesterol, triacylglycerol, and C-reactive protein (CRP)) in F 16-49 y 
(NHANES 99-02), and if mercury attenuated any cardio-protective benefits. 
Results:  Fish FFQ was negatively associated with CRP (95% CI: -0.19 to -0.02, p=0.015) and 
positively associated with HDL (95% CI: 0.31 to 2.5, p=0.014), and was not significantly 
attenuated after adjustment for multiple other risk factors.  Addition of mercury resulted in non-
significant relationships between fish FFQ and HDL (95% CI: -0.60 to 1.6, p<0.05).  
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Chapter 1:  Introduction and Literature Review 
Introduction  
The major aim of this study was to use the most recent National Health and Nutrition 
Examination Survey (NHANES 1999-2002) data (1) to investigate the relationship between 
frequency of fish consumption and the marine-based omega-3 fatty acid [(eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA)] intake, and risk markers of coronary heart disease 
(CHD) and the effects of total blood mercury (TBHg) on these relationships.  The study was 
limited to female participants aged 16-49 years for whom data on TBHg were available.  The 
tested hypotheses were as follows: (1) 30-day frequency of fish intake and 24-hour DHA+EPA 
intake are negatively associated with serum concentrations of total cholesterol (TC), LDL 
cholesterol (LDL), triacylglycerol (TG), and C-reactive protein (CRP), and positively associated 
with high density lipoprotein cholesterol (HDL) concentrations and, (2) TBHg attenuates the 
cardio-protective benefits of DHA+EPA as assessed by TC, LDL, TG, HDL and CRP 
concentrations, controlling for multiple known confounders. 
To date, seven studies have addressed the combined effects of omega-3 fatty acids (from 
food or dietary supplement sources) or fish intake and marine derived mercury (Hg) on the risk 
of CHD.  Five studies used male participants only; one used female participants only; and one 
evaluated both men and women.  Of the seven studies, three used subjects from the high fish 
consuming populations in Finland, a fourth study was conducted in men from eight European 
countries, a fifth study looked at male health professionals within the US, the sixth investigated 
both men and women from Sweden, and the seventh was conducted in Swedish women only.  





from fish consumption (2-5).  Two studies failed to demonstrate a significant association 
between Hg and CHD (6, 7) and one study reported a negative association between measured 
Hg concentrations and CHD (8).  These studies are reviewed in detail further in the text.   
Six of the seven previous reports that evaluated the combined effects of fish (or 
DHA+EPA) and Hg on CHD were performed only in male subjects, while one study also 
included women.  The method of assessing Hg exposure (including measurements in hair, 
serum, blood and toenail) varied according to study.  The hypothesis that consuming fish with 
high Hg concentrations may diminish the cardio-protective effects of fish remains uncertain 
particularly with respect to women.  Our study extends the work of previous researchers and 
contributes to the ongoing scientific and public health policy debate on the benefits and risks of 
fish consumption, particularly in women.  
Evaluation of Existing Knowledge and Availability of Data 
 The most recent NHANES data (1999-2002) reported by the National Centers for Health 
Statistics (NCHS) included measurements of blood, hair, and urine Hg (total and inorganic) for 
women of childbearing age (16-49 years) to assess Hg exposure from fish.  Blood and hair 
measures were also included for children aged 1-5 years.  The NHANES (1999-2002) included 
a 24-hour food intake history from which DHA+EPA intake was derived, and a 30-day fish food 
frequency questionnaire (FFQ) for 31 varieties of fish and shellfish.  Shellfish were excluded 
from the analysis because few shellfish contain Hg (9). 
 In the current study using the NHANES (1999-2002) data, there were five dependent 
variables of interest related to CHD risk, including 4 lipid biomarkers (LDL, HDL, TC, TG) and 
the inflammatory marker, CRP.  In addition, the NHANES (1999-2002) data set includes a 





physical activity, diabetic status, smoking status, use of prescription medications, and age.  The 
analysis target sample was limited to women aged 16-49 years for which TBHg was measured.  
The risk markers for CHD and other variables known to affect CHD risk are reviewed in detail 
below.     
Risk Markers of CHD 
Abnormal blood lipid levels contribute significantly to the risk of CHD, and this is 
compounded by other risk factors (10).  The dependent variables serving as risk markers in the 
current study were serum LDL, HDL, TC, TG, and CRP concentrations.  The use of both lipid 
and inflammation biomarkers to assess risk in postmenopausal women is supported by recent 
research.  Ridker and colleagues demonstrated that models in apparently healthy 
postmenopausal women, which incorporated markers of inflammation as well as lipids, were 
significantly better at predicting CHD risk in apparently healthy postmenopausal women than 
models based on lipid levels alone (p<0.001) (11). 
C-reactive protein 
CRP is considered one of the best measures of acute phase response to an infection, 
disease, or other cause of tissue damage and inflammation and is well established as a predictor 
of cardiovascular disease (11).   Multiple studies have demonstrated that elevated inflammatory 
markers, including CRP, indicate an increased risk of CHD (12).  CRP can be used to measure 
the body’s response to chronic conditions including arthritis and chronic smoke inhalation (1).    
Since many markers of inflammation may not be tissue specific, there is error involved in using 
some markers as independent predictors of a particular disease.   
CRP is affected by numerous lifestyle variables.  In general, individuals with elevated 
CRP tend to smoke, have high blood pressure, are overweight, and fail to exercise (13).  





clinical cutoff points established for CRP are “low” (<1.0 mg/L), “moderate” (1.0 to 2.9 mg/L) 
and “high” (> 3 mg/L) (14).   
 CRP was shown to be a valuable predictor of CHD risk in women.  Female participants 
in the Nurses Health Study who suffered from CHD during 8 years of follow-up had 
significantly higher CRP concentrations than healthy controls (3.1 mg/L vs 2.2 mg/L, p<0.001) 
even after adjusting for multiple other CHD risk factors (12).  The Women’s Health Study 
enrolled 27,939 apparently healthy post-menopausal women aged > 45 years between 1992 and 
1995 who were then followed up for 9 years or until the first cardiovascular event.  Compared to 
women with baseline CRP concentrations of <1 mg/L, the crude relative risk for post 
menopausal women with CRP concentrations of 1.0 to 2.9 mg/L was 1.7 (95% CI, 1.4 to 2.2) 
whereas the relative risk (RR) was greatest for those with CRP concentrations >3 mg/L (3.0, 
95% CI, 2.4 to 3.7) (p for trend across groups was <0.001) (15).  The predictive value of CRP 
demonstrated similar effects in male subjects.   
A newer method of measuring CRP is available and is called high sensitivity CRP 
analysis [(hs) CRP].  Both CRP and (hs) CRP methods measure the same molecule in the blood.  
The (hs) CRP method has been used to determine risk of CVD for seemingly healthy people and 
ranges from 0.5 to 10 mg/L.  The CRP test is ordered for patients at risk for bacterial or viral 
infection (such as following surgery) or patients with chronic inflammatory diseases and ranges 
from 10 to 1000 mg/L.  The NHANES (1999-2002) documentation does not specify that the 
(hs) CRP test was used; however, the levels reported in the female participants aged 16-49 years 
are consistent with a (hs) CRP test rather than CRP (16). 
Other markers of risk proposed for use in screening include homocysteine, fibrinogen, 





lipoprotein.  These biomarkers have limited clinical use, however, because there are inadequate 
standardization of assay conditions, prospective data are inconsistent or non-existent, and these 
markers, when incorporated into prediction models, did no better than conventional lipid 
screening in predicting risk (17).   
Total cholesterol 
In a prospective cohort study (EUROASPIRE), men and women with established CHD 
were followed from baseline for five years.  Patients who died of CHD related causes had 
significantly higher total cholesterol at baseline than patients who survived (6.61 mmol/L vs 
6.07 mm/L, p=0.002).  In addition, patients who died had lower HDL concentrations at baseline 
than survivors (1.20 mmol/L vs 1.23 mm/L), however the difference was not significant (18).  
Based upon the results of the Framingham Study, researchers reported that screening for TC 
alone in women aged 50 years and older may not be adequate for identifying individuals at risk 
for CHD (19).    
HDL cholesterol 
Low concentrations of HDL are often associated with a non-healthy lifestyle such as, 
smoking, lack of regular exercise, and being over weight.  A strong inverse relationship exists 
between plasma HDL concentrations and CHD risk in both sexes (19).  Rates of MI were 
significantly greater for female Framingham participants (aged 50 to 79 years) in the lowest 
quartile of HDL concentration (23 to 46 mg/dL) compared to those in the highest HDL quartile 
(67 to 139 mg/dL) (p<0.05).  After adjusting for age and other risk factors, participants in the 
lowest HDL quartile experienced nearly six times the number of coronary events compared to 
those in the highest quartile of HDL concentrations (p<0.001) (19).   





Other blood lipids such as LDL and triacylglycerol (TG) are valid predictors of CHD 
risk.  However, triacylglycerol was only measured in a subset of the population in NHANES.  
Since LDL calculation is based on TG, these variables were limited to a subset of the 
population. 
Factors that may affect these CHD risk markers along with variables that were evaluated 
as confounders in the current research are described below. 
Omega 3 fatty acids 
Previous reports on the relationship between marine derived omega-3 fatty acids and the 
risk of CHD have varied according to age, gender, and disease state of the subjects, with the 
majority of the studies conducted in men.  Observational studies have shown that the inverse 
association of fish or marine omega-3 fatty acid intake with CHD is stronger in high risk versus 
low risk populations (20).  The NHANES sample used in this study included women aged 16-49 
years in whom the CHD risk varied greatly.  Because age is a risk factor for CHD, the subjects 
in this study were stratified by decade (ie., 20-29, 30-39 and 40-49 years), with subjects aged 
16-19 years used as the reference group. 
Established relationships between omega-3 fatty acids, fish and CHD 
In 2000 a Joint Task Group (JTG) consisting of the Consumer Healthcare Products 
Association, Council for Responsible Nutrition and National Fisheries Institute conducted a 
systematic review of publications related to omega-3 fatty acids and CHD, in support of a 
proposed qualified health claim for omega-3 fatty acids.  The JTG found 16 observational 
studies and rated 9 as “good to moderate”.  These nine studies all reported a negative association 
between omega-3 fatty acids and CHD.  Studies that did not demonstrate protective effect of 
omega-3 fatty acids on CHD had limitations such as short duration time or lack of adequate 
follow up.  Prospective cohort studies using initially healthy populations generally require a 






minimum of 10 years of follow-up since CHD is a slowly progressive disease.  One study 
evaluated women, all of whom were older adults (all born before 1907). 
Dietary supplements of omega-3 fatty acids vary widely according to dose and the ratio 
of EPA to DHA.  A 12-week parallel double-blinded supplementation study that provided 1.5 
g/day omega-3 fatty acids (EPA/DHA ratio of 0.67) resulted in a non-significant association 
with markers of inflammation (CRP) in apparently healthy male and female volunteers aged 20 
to 55 years (21).  A recent study evaluated the effects of 2.8 g/day DHA supplementation 
(alone) on cardiovascular disease risk factors in post menopausal women (aged 45-79 years) 
using a double blind, placebo controlled cross over design.  The subjects recorded their own 
dietary intake during the two 28-day study periods (placebo or DHA supplement).  Data on 
physical activity were not collected. The authors found that DHA supplementation had no 
significant relationship with blood levels of CRP, but raised HDL concentrations by 8% 
(p=0.017) (22).  When healthy post- menopausal women were supplemented with 14g/day or 14 
g/day safflower oil, those consuming fish oil had significant decreases in CRP, TG and the ratio 
of TG to HDL (23).  Supplements in the range of <1g/day to 4g/day taken by different samples 
of subjects have produced varying results on biomarkers of inflammation.  Intervention trials 
have not found a significant association between omega-3 fatty acids (both marine and plant 
based) and CRP.  Male and female type 2 diabetic subjects with an average aged of 61.2 years 
who were supplemented with 4 g/day DHA+EPA did not have significant changes in CRP 
concentrations (24).  Whereas observational studies as described above have seen significant 
associations between these fatty acids and CRP (25).  Only 1.6% of participants in the Nurses 
Health Study (women aged 30-55 years) reported taking omega-3 fatty acid supplements, 





Fish consumption has been shown to be cardio-protective in women.  Among female 
participants in the Nurses Health Study (aged 30-55 years), fish consumption was inversely 
associated with the incidence of CHD (p=0.003) (26).  Compared to women who seldom ate fish 
(<1 serving per month) the relative risks of CHD (adjusted for age, smoking and other known 
CHD risk factors) were 0.70 (95% CI: 0.48 to 1.03) for fish consumption 1 to 3 times per 
month, 0.60 (95% CI: 0.42 to 0.85) for once per week, 0.64 (95% CI: 0.42 to 0.99) for 2 to 4 
times per week and 0.36 (95%: CI 0.20 to 0.66) for five or more times per week (p for trend= 
0.002) (27).  Despite the evidence that fish consumption is beneficial for cardiovascular health 
and tends to increase with age (28) fish intake remains low in the US (1).   
 A recent meta-analysis quantified CHD risk as a function of fish consumption (number 
of servings/week) and took into account any risks derived from marine based methyl Hg 
exposure.  The authors concluded that consuming >1 serving of fish per month is associated 
with a 17% reduction in CHD mortality risk, with an additional 3.9% risk reduction for each 
additional serving of fish per week (29).   
Mechanism of omega-3 fatty acids on CHD 
Omega-3 fatty acids protect against CHD by a variety of physiological mechanisms, 
which include lowering plasma TG concentrations, inhibiting plaque formation, decreasing 
platelet aggregation and altering arrhythmogenesis (30).  These effects have occurred in humans 
and animals with both food and dietary supplement sources of omega-3 fatty acids. 
Methyl Mercury 
 Total Hg (often measured in hair and blood) is composed of inorganic and organic Hg.  
There are multiple sources of exposure to inorganic Hg including dental amalgams, “folk” or 





trace amounts in eggs, organ meats, and kidney, and occupational exposure (31).  Organic Hg 
(methyl Hg) is present in fish due to its uptake from environmental sources.  It occurs in soil, 
rocks, streams, lakes and oceans as a result of burning fossil fuels.  Other sources of organic Hg 
are industrial wastes such as thermometers, batteries, electrical switches, Hg based paint, 
pesticides, and fungicides, and byproducts of the mining and pulp and paper processing 
industries (32).  In humans, the sole source of exposure to organic Hg is the consumption of fish 
and sea mammals (33).  Organic Hg found in fish and shellfish has repeatedly been confirmed 
as being methyl Hg (31).  Most fish have trace amounts of Hg because of the metals’ tight 
protein binding properties.  Mercury levels in fish vary depending on the aquatic environment 
(e.g., proximity to industrial mercury sources) and place in the food chain.  Large long-living 
predatory fish have been shown to contain the greatest amounts of methyl Hg (9).  In this study, 
references to dietary Hg are organic methyl Hg (Hg) unless indicated otherwise. 
 Risk of Mercury Intake 
The risk associated with eating fish contaminated with Hg varies among the population.  
The Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) jointly 
released a revised consumer advisory on Hg toxicity in fish aimed at the most sensitive groups, 
including pregnant women, nursing mothers, women who may become pregnant, and young 
children (34).  Mercury has adverse neurological effects on the developing fetus and can retard 
psychomotor development in young children (35).  Research has linked Hg ingestion from fish 
to increased risk of CHD (2-5, 7).  The cardiovascular effects of Hg from fish are not included 





Mechanism of action 
NHANES (1999-2002) provided total blood Hg for a subset of women aged 16-49 years.  
Ninety percent of Hg is located in red blood cells and a small percentage is metabolized into Hg 
ions (32).  Erythrocytes and plasma contain even distributions of metallic and inorganic Hg 
whereas organic Hg is greater in erythrocytes than in plasma (35, 36).  All exposure to Hg 
(inorganic and organic) is reflected in blood.  After Hg is ingested it can easily pass through 
cellular membranes, resulting in neurotoxic effects (35).  Once absorbed, inorganic Hg is 
excreted in the urine (32).  NHANES (1999-2000) provided data on urinary Hg concentrations, 
which reflect exposure to inorganic Hg from environmental sources rather than from the dietary 
intake of organic Hg from marine sources.  Therefore, urinary Hg data were not included in the 
current study.  Approximately 90% of absorbed organic Hg is excreted in the feces, but fecal 
biomarkers were not collected by NHANES.  Once absorbed, the average half-life of Hg in 
humans is 70 days, but it can vary among individuals from 35 to 189 days (35, 36).  Thus, the 
amount of Hg measured in total blood in NHANES is representative of the fish reported 
consumed in the NHANES 30-day fish FFQ.   
Established relationship of mercury and fish consumption 
The half life of Hg in blood, which is >30 days, allows the use of total blood Hg levels 
measured in NHANES to represent Hg derived from fish, as reported in the 30-day FFQ and the 
24-hour dietary recall.  Studies to date have demonstrated significant positive relationships 
between fish consumption and Hg levels.  Three studies have been published using the 
NHANES (1999-2000), all of which found positive associations between Hg (in hair and blood) 
and fish intake.   
The relationship between hair Hg concentrations, blood Hg levels, socio-demographic 





(37).  The subjects were 1,726 females aged 16-49 years, including 292 pregnant women.  Fish 
FFQ responses were analyzed according to type (fish or shellfish) and frequency (0 times, 1-2 
times, or >3 times in 30 days).  The mean hair Hg concentration was 0.47 ug/g (95% CI: 0.35 to 
0.58).  When analyzed by age, mean hair Hg increased with each decade.  For example, 
compared to women ages 16-19, women 30-39 and 40-49 years of age had significantly greater 
hair Hg levels (p<0.05). 
Prior to the release of the 1999-2000 NHANES hair Hg data, the NHANES only 
included data on blood Hg levels.  Schober et al, (2003) published the initial report on total 
blood Hg data (NHANES 1999-2000) (38).  The geometric mean concentration of total blood 
Hg for the 1,709 women was 1.02 ug/L (95% CI, 0.85-1.20 ug/L).  Women who ate 3 or more 
servings of fish per month had a four-fold greater geometric mean Hg level compared to non 
fish consuming women (1.94 ug/L vs 0.51 ug/L; p<0.001). 
The NHANES did not provide organic Hg measurements but only total blood Hg 
concentrations.  However, MaHaffey et al (2004) described the association between total blood 
Hg levels and the calculated organic Hg intake derived from the methyl Hg in fish and shellfish 
(1999-2000 NHANES) (31).  Fish were the major source of organic Hg.  Fish consumption was 
derived from the NHANES 30-day fish FFQ.  The Hg content of fish and shellfish were derived 
from the National Marine Fisheries Service database.  The authors multiplied fish intake per 
eating occasion (39) by the 30-day fish FFQ to determine average monthly fish consumption in 
grams.  Average monthly fish intake was combined with the Hg content of fish to determine 
estimated monthly organic Hg intake.  These values were compared to the total blood Hg 
NHANES data.  Blood organic/methyl Hg was greatest for participants who classified 





Pacific Islanders (geometric mean=1.06, 95% CI:  0.18-1.34).  Blood organic/methyl Hg 
concentrations increased by approximately 0.2 ug/L per decade of age.  This increase was 
consistent with findings from the other blood and hair Hg analyses previously conducted.  
Women who reported at least 9 occasions of fish or shellfish consumption within the past 30-
days had total blood Hg concentrations almost seven times higher than non-consumers (2.49 
ug/L compared to 0.39 ug/L).  The calculated blood organic Hg was greatest for those who 
reported consuming fish > 9 times per week (2.70 ug/L, 95%CI: 1.51-3.89); however, this group 
also comprised the smallest sample (n=63).  The adjusted multiple correlation coefficient (R) for 
the association between quantity of fish and shellfish eaten per kg of bodyweight and blood Hg 
was 0.54 for total blood Hg and 0.55 for calculated organic blood Hg.  The authors separated 
consumption by type of fish.  Tuna (one of the two most commonly consumed fish), and “other 
fish” were both significant predictors of blood Hg (p<0.05).  Overall, shellfish consumption (log 
shellfish) had minimal to no effect on total blood Hg and organic blood Hg.  However, each 
gram of shellfish and fish consumed (per kg bodyweight of the subject) resulted in a 0.2 to 0.5 
ug/L increase in blood Hg concentrations.   
Several prospective studies reported significant associations between fish consumption 
and Hg biomarkers in men (2-5, 40).  One study was conducted with 1,833 middle-aged men in 
the Finland Health Registry who were followed prospectively for 7 years.  The men reported an 
average fish intake of 46.5 g/day and had hair Hg concentrations of 2 mg/kg.  Men in the highest 
tertile of hair Hg content (>2.0 µg/g) had a 2.0-fold greater age- and CHD-adjusted risk of acute 
MI (95% CI: 1.2 to 3.1; P=0.005) and a 2.9-fold greater adjusted risk of cardiovascular death  





A study conducted in Finnish men aged 42-60 years without prior CHD or stroke found 
that fish intake in men with the highest tertile of hair Hg was more than twice that of men in the 
lowest hair Hg tertile (65 vs 30 g/day; p<0.001).  High hair Hg was strongly associated with fish 
consumption (r=0.27; p<0.001) and serum DHA + EPA concentrations (r=0.25; p<0.001) (2).   
Guallar et al (5) evaluated the relationship of Hg measured in toenails and DHA 
measured in adipose tissue on the risk of having a first MI.  Concentrations of DHA in adipose 
tissue were strongly correlated with toenail Hg (p<0.0001).  Similarly, a nested case control 
design in male health professionals aged 40-75 years found a positive relationship between fish 
consumption and toenail Hg concentrations (r=0.42, p<0.001) (40).  In a nested case control 
study conducted on Swedish men and women aged 30-60 years, erythrocyte Hg was 
significantly greater in subjects who reported > 1 fish meal per week compared with those 
reporting <1 fish meal per week, irrespective of the type of fish (lean or fatty) consumed 
(p<0.001) (7).   
Effects of mercury on risk of CHD 
Seven studies have investigated the combined effects of omega-3 fatty acids (from food 
or dietary supplements) or fish intake and marine derived Hg on the risk of CHD.  Five studies 
used male participants only; one used only females; and one evaluated both men and women.  
Of the seven, three were conducted on the high fish consuming populations in Finland, a fourth 
study was conducted in men from eight European countries, a fifth study looked at male health 
professionals within the US, the sixth investigated both men and women from Sweden, and the 
seventh was conducted in Swedish women.  Four of the seven studies reported that Hg might 





failed to demonstrate a significant association between Hg and CHD (6, 7) and one study 
reported a negative association between Hg concentrations and CHD (8).   
One of the first studies was conducted with 1,833 middle-aged men selected from the 
Finland Health Registry.  Over the 7-year observation period, average fish intake was 46.5 g/day 
and hair Hg was 2 mg/kg.  Men with hair Hg in the highest Hg tertile (2ppm or higher) had 
twice the risk of an acute myocardial infarction than the remainder of the study sample (RR 1.7, 
p=0.038) (3). 
A follow up study of the Finnish cohort of 1,871 middle-aged men conducted in 2000 
prospectively measured marine derived omega-3 fatty acids.  Participants in the upper quintile 
of omega-3 fatty acid intake and having low hair Hg concentrations (<2 ppm) demonstrated a 
67% reduction in MI risk (p=0.016).  Conversely, participants in the highest quintiles of omega-
3 fatty acids and high hair Hg demonstrated a 24% reduction in risk (4).  Men in the two lowest 
tertiles of hair Hg who were also in the highest quintile of serum DHA + EPA had a 67% 
reduced risk of acute coronary events compared to men in the highest third of hair Hg and 
lowest quintile of serum DHA+EPA (95% CI: 19% to 87%; p=0.016).  The authors concluded 
that high Hg in fish may attenuate the cardio-protective effects of omega-3 fatty acids in middle 
aged men (4). 
A third study, conducted in Finnish men aged 42-60 years without prior CHD or stroke 
(n=1,871), investigated the effects of elevated hair Hg content on the risk of acute coronary 
events and cardiovascular all-cause mortality.  Subjects with “high” hair Hg content (>2.03 
ug/g) had a 1.60 fold greater adjusted risk of an acute coronary event (95% CI: 1.24 to 2.06) and 
a 1.68 fold greater risk of CVD (95% CI: 1.15 to 2.46) than the lower two thirds.  The authors 





events.  It also may increase the risk of CVD, CHD and all cause mortality in middle aged 
eastern Finnish men, as well as attenuate the protective effects of fish (as assessed by serum 
DHA levels) on cardiovascular health (2).   
Guallar et al. (5) evaluated the relationship of Hg measured in toenails and DHA 
measured in adipose tissue on risk of first myocardial infarction (MI).  After adjustment for age, 
location and DHA, MI patients had higher toenail Hg than the healthy controls [odds ratio; 1.10 
(95% CI: 1.03-1.18)].  The researchers concluded that high toenail Hg diminished the cardio 
protective effect of fish intake.   
A nested case control design in male health professionals aged 40-75 years failed to 
demonstrate a significant relationship between Hg and CHD.  The researchers found a positive 
relationship between fish consumption and toenail Hg (r=0.42, p<0.001) levels but no 
significant increase in risk of CHD with higher toenail Hg concentrations even after adjusting 
for age, smoking and other risk factors (40).   
Conversely, a population based case control study in both men and women, aged 30-60 
years, found a significant effect of blood Hg on risk of MI.  In a multivariate model, the risk of 
MI was lower for subjects with both high erythrocyte Hg and high plasma DHA+EPA (OR= 
0.16, 95% CI: 0.04 to 0.65) than for plasma DHA+EPA alone (7).  This association may be 
more indicative of the benefits of fish consumption rather than a protective effect of blood Hg.   
Finally, a study conducted in 1,462 Swedish women aged 38-60 years at baseline found 
a protective effect of serum Hg.  The authors followed the women for 24 years.  After 
controlling for age and education, the correlation between MI and serum Hg was less than zero, 
indicating a protective effect of Hg.  The authors did not control for omega-3 fatty acids or fish 





In summary, the majority of the studies to date that evaluated the combined effects of 
fish (or DHA+EPA) and Hg on CHD were case control studies using male subjects.  One of the 
six studies also included women.  The majority of the studies in men demonstrated a positive 
association between Hg and CHD; however, additional research is needed on the benefits from 
fish as well as fish variety (e.g. lean versus fatty fish). 
Variables other than omega-3 fatty acids and methyl mercury that may affect risk 
markers of CVD 
Age and BMI 
 It is well understood that the risk of CHD increases with age as well as with an increase 
in non-lean body weight.  Body mass index (BMI) is often used as a measure of weight for 
height and is calculated as weight (kg) divided by height squared (m2).  BMI is not the most 
accurate measure of healthy body weight because it does not account for the difference in lean 
versus non-lean tissue.  It can be inaccurate for the young, the elderly, and athletes who have 
high muscle mass, as muscle tissue is denser than fat tissue.   
Diabetes, arthritis, stress, trauma and pregnancy 
Obesity, insulin resistance, diabetes, hypertension, and low HDL concentrations are all 
associated with increased production of inflammatory markers including CRP (12).  Diabetes is 
a disease associated with impaired glucose metabolism and insulin resistance, and diabetics are 
at a high risk for atherosclerosis and cardiovascular related diseases (41).  Other conditions 
associated with inflammation and inflammatory biomarkers include arthritis, burns, sepsis, 





Medical history of coronary heart disease 
 Dyslipidemia is associated with an increased risk of CHD and is characterized by 
elevated levels of LDL (>160 mg/dL), TG (>200 mg/dL) and TC (>240 mg/dL), and a low level 
of  HDL (<40 mg/dL) (16).   
Antioxidant Intake   
Epidemiological studies investigating the role of antioxidants in reducing the risk of 
CHD have produced inconsistent results.  Clinical studies conducted in 1999 to 2002 typically 
focused on dietary intakes of vitamins E, C, and B-carotene in post-MI or other high-risk 
patients.  Five studies which evaluated vitamin E supplementation, in doses ranging from 300 
mg of synthetic to 400 IU of natural vitamin E, had no effect in reducing the risk of MI, CHD, 
death or stroke for high risk (post MI and diabetic) adults.  Similarly, no effects were seen in 
studies using B-carotene or mixtures of antioxidants (43).   
Because diabetic patients have an increased risk of CHD, considerable attention has been 
focused on this population group.  A study in type II diabetic patients found that vitamin E had 
anti-inflammatory effects resulting in reduced plasma concentrations of CRP, while vitamin C 
had no effect on CRP (44).   
In a randomized trial on a cohort of passive and active smokers, Block et al (2004) found 
that the administration of 515 mg/day vitamin C resulted in a 25% reduction in CRP 
concentration (95% CI: -38.9 % to –5.5%; p=0.036) after adjusting for BMI and baseline CRP 
levels.  However, no significant effects were seen in subjects receiving an antioxidant mixture 
or placebo.  Participants in this study were limited to “healthy” active and passive smokers (both 





the analysis was adjusted only for BMI and CRP and not for any other dietary variables, these 
results may not be reliable. 
Food sources of alpha tocopherol (AT) include wheat germ oil, sunflower and peanut 
oils, margarines, almonds, sunflower seeds, peanuts and peanut butter (45).  Numerous studies 
have failed to show that AT significantly affects inflammation biomarkers.  For example, there 
was no effect on inflammation when subjects were supplemented with 800 IU/d all-rac AT as 
opposed to the significant inverse association commonly found with the natural RRR-AT isomer 
(46).  Current research has shown that the “natural” form of vitamin E has approximately twice 
the bioactivity in humans than the synthetic vitamin (45), and it has been suggested that 
“natural” vitamin E (AT) may protect omega-3 fatty acids from lipid peroxidation (42).   
Despite the initially promising hypothesis, observational studies have failed to 
demonstrate cardio-protective effects of supplemental AT.  The GISSI study (1999) randomized 
men with a recent MI to one of 3 dietary supplement groups:  omega-3 fatty acids alone (0.86 
mg EPA+DHA), vitamin E alone (300 mg synthetic AT), or a combination of both.  This study, 
as well as others (21), used synthetic AT and did not find a significant relationship between AT 
supplementation and the risk of a second MI.     
Fish is a rich source of selenium, an essential trace element antioxidant.  Other dietary 
sources of selenium include bread, cereal, poultry and meat.  Studies of dietary intake of 
selenium on cardiovascular disease have yielded inconsistent results (47).  A secondary analysis 
in a randomized trial showed no significant associations between daily selenium 
supplementation (200 ug/day) and cardiovascular disease endpoints during the 7.6 years of 





exclude the possibility that selenium in combination with other foods (such as fish) or nutrients 
may have cardiovascular benefits. 
Anti-inflammatory effects of aspirin and other hypolipidemic drugs 
In 1997, the American Heart Association (AHA) issued a statement for healthcare 
professionals on the therapeutic effects of aspirin in patients with cardiovascular disease (CHD) 
(48).  Aspirin can reduce the risk of occlusive vascular events by inhibiting platelet aggregation.  
Numerous studies have been conducted with aspirin in high-risk patients (men with history of 
CHD) but few primary prevention studies on aspirin and CHD risk have been done, especially 
in women.  Two prospective cohort studies reported statistically significant reductions in the 
risk of a first MI in adult men who consumed aspirin (48, 49).  After alternate-day dosage of 
325 mg, the risk of a first MI in 22,071 participants in the US physicians health study was 
reduced significantly by 44%.  However, a smaller cohort study in Britain failed to find a 
significant reduction in CHD risk after aspirin supplementation (48).   
In March 2005, the Women’s Health Initiative study published findings from a 
randomized prospective cohort of women aged 45 years and older (50).  The women received 
100 mg aspirin or placebo every other day and were followed for ten years for a first 
cardiovascular event.  Women who consumed aspirin had a non-significant 9% reduction in risk 
of a first cardiovascular event (95% CI: 0.8 to 1.03, p=0.13).  Aspirin significantly reduced the 
risk of stroke by 17% in the treatment versus placebo group (RR 0.83, 95% CI: 0.69 to 0.99, 
p<0.04) (51).   
In addition to aspirin, other medicines are prescribed to reduce the risk of CHD by 
lowering blood lipids and CRP.  Drugs that are used to lower CRP include statins, glitazones, 





recent studies demonstrated the beneficial effects of statins on blood lipid profiles and CRP.  A 
randomized trial performed between 2000 and 2004 used a two-by-two factorial design to 
compare the effects of intensive and moderate statin therapy and gatifloxacin versus placebo on 
the risk of recurrent coronary events after acute coronary syndromes in 3,745 male and female 
patients (mean age of 58 years).  Statin therapy resulted in lower LDL and CRP in patients (p 
values not provided) (53).   
Nissen and colleagues (2005) conducted a similar study in which 502 patients with CHD 
were randomly assigned to receive either moderate (40 mg/day of prevastatin) or intensive (80 
mg/day of atorvastatin) statin treatment over 18 months.  Comparison of baseline versus post-
treatment CRP, LDL, and TC for the combined sample (moderate and intense drug use) 
demonstrated significant decreases.  LDL concentrations post treatment decreased from 150.2 
mg/dL to 94.5 mg/dL (p<0.001); CRP concentrations decreased from 2.9 to 2.3 mg/L, p<0.001 
and TC concentrations decreased from 232 mg/dL to 169.2 mg/dL, p<0.001.  Treatment resulted 
in non-significant increases in HDL concentrations (42.6 mg/dL to 43.8 mg/dL, p=0.11) (54).   
Estrogen and other hormones affect hepatic lipid and lipoprotein metabolism.  During 
menopause, the body decreases the production of estrogen, resulting in significant reductions of 
circulating levels of estradiol and estrone (55) which adversely affect blood cholesterol and CRP 
concentrations.  Therefore, postmenopausal women have an increased risk of CHD, not only 
due to advancing age but also because serum levels of TG, TC, and LDL are increased while 
HDL levels decrease (56).  Some postmenopausal women choose to take hormones, i.e. 
hormone replacement therapy.  Several case control studies and clinical trials demonstrated that 





Exercise and physical activity 
It is generally recognized that habitual physical activity helps to reduce the risk of CHD 
and alleviate symptoms associated with CHD in diagnosed patients.  In particular, physical 
activity may prevent such risk factors as high blood pressure, insulin resistance, glucose 
intolerance, elevated TG concentrations, low HDL concentrations, and obesity.  In combination 
with weight reduction, physical activity can decrease LDL and elevate HDL concentrations.  
The AHA summarized the evidence for the benefits of physical activity in the prevention and 
treatment of CHD.  Data have consistently shown a graded inverse relationship between 
coronary artery disease rates and levels of physical activity.  The magnitude of the effects of 
exercise is influenced by type, duration, intensity, and frequency of exercise, the extent of 
weight lost, and individual variation.    
 
Dietary fiber 
 Diets high in complex carbohydrates and fiber are associated with reduced mortality 
rates from CHD (58).  Epidemiological studies have repeatedly shown the lipid-lowering effects 
of diets rich in fruits and vegetables, which are good sources of both soluble and insoluble fiber 
and tend to be low in fat.  Pereira et al (2004) analyzed the original data from 10 prospective 
cohort studies from the United States and Europe to study the association between the risk of 
CHD and intake of dietary fiber derived from cereal, fruits, and vegetables, as well as whether 
the fiber was soluble (pectins, gums, and mucilages) or insoluble (hemicellulose, cellulose, and 
lignin).  Data on fiber derived from cereals, fruits, and vegetables were available for all of the 
studies, but only 2 studies included estimates of insoluble and soluble fiber.  The authors noted 
that there is not a standard method for estimating these fiber types based on food tables, so the 





10 years of follow-up, 5,249 incident total coronary cases and 2,011 deaths occurred in 91,058 
men and 245,186 women.  After adjusting for demographics, BMI, and lifestyle factors, each 
10g/day increment of total dietary fiber (adjusted for energy and corrected for measurement 
error) was associated with a 14% decrease in risk of all cardiovascular events (RR=0.86, 95% 
CI, 0.78 to 0.96) (59).   
Several mechanisms have been proposed to explain how fiber reduces the risk of 
cardiovascular disease, but none have been proven.  To ensure nutrition and maximize the 
cholesterol-lowering impact of a healthy diet, the AHA recommends a total dietary fiber intake 
of 25 to 30 g/day from foods (not supplements). 
 
Dietary trans-fatty acids 
Efforts to estimate the dietary intake of trans fatty acids (or trans fats) in the US are 
difficult because a complete database for the trans fatty acid content of foods is not available.  
Therefore, most intake estimates are based on disappearance data, food-questionnaire data or 
analysis of self-selected diets (60).  Clinical data have shown consistently that trans fatty acid 
intake results in higher plasma cholesterol levels compared to other native oils and saturated 
fats.  Due to the static temporality nature of cross sectional studies and the limited information 
on trans fat content of foods, epidemiological studies that have investigated the relationship 
between trans fat intake and CHD risk have yielded inconsistent results (60).  The NHANES 
(1999-2002) did not separate out trans fat from data on other fats obtained during the 24-hour 







Depending on the “dose,” alcohol consumption has been shown to be either a protective 
or harmful variable in determining the risk of heart disease.  Observational studies in middle 
aged or elderly men and women demonstrated a decreased risk of CHD with moderate 
consumption of alcohol, but this relationship appears to be J-shaped (14).  Consuming 1-2 
drinks/day was associated with a 30-50% reduction in CHD risk.  Based on the total body of 
evidence available, the AHA concluded that moderate consumption of alcohol does support a 
true protective effect.  Heavy consumption of alcohol as seen in alcoholics, however, appears to 
adversely affect the heart muscle and arterial tissues.  According to the Health, Aging and Body 
Composition Study of 2,574 healthy elders, moderate drinking (1-7 drinks/week) resulted in 
lower levels of markers of inflammation (CRP and IL-6) compared to heavy drinking (>7 
drinks/week) or no drinking at all (15).  Alcohol consumption (g/day) was reported in the 
NHANES (1999-2002) 24-hour dietary recall interview.  
 
Smoking Status 
 Tobacco smoke is harmful to overall health.  In a 1997 report on cigarette smoking, 
cardiovascular disease and stroke, the AHA concluded that 30% of deaths due to CHD were 
attributable to cigarette smoking, and the risk was dose dependent.  Cessation of smoking 
reduces the risk of CHD.  Cigarette smoking also is associated with elevated levels of CRP (52) 
and other inflammatory markers (12).  Levels of serum cotinine (a metabolite of nicotine) can 







Chapter 2:  Methods  
Data 
The NHANES is a stratified, multistage probability sample of the civilian non-
institutionalized U.S. population, which interviews approximately 5,000 people in their homes 
per survey year.  The respondents complete a health examination component in mobile 
examination centers (MEC).  Low-income persons, adolescents 12-19 years, people over 60 
years old, African Americans and Mexican Americans are over-sampled (1).  Two of the major 
objectives of the NHANES are to estimate the number and percent of persons in the US with 
selected diseases and risk factors, and to study the relationship between diet, nutrition and health 
(1).   
Population 
 The sample population of interest is limited to women ages 16-49 years for whom blood 
Hg data are available.  Variables measured in NHANES are separated by collection year (1999-
2000 and 2001-2002), by type of data collection (i.e. demographic, examination, laboratory or 
questionnaire), and further subdivided by category of variable (e.g. total nutrient intake, 
cardiovascular health, physical activity).  All of the files are linked by the common participant 
number (variable name SEQN).  The methodology for the variable selection and data merging in 
the current study is as follows: 
1) All variables of interest by were merged by collection year, noting that not all survey 
participants had valid data for the variables of interest.   
2) When a person did not have a measured value or did not participate in the portion of 





3) Once the variables were merged for one collection year for the entire NHANES 
population, the frequencies were checked for completeness in the combined dataset 
to those published for each variable in the NHANES website. 
4) The same methodology, as described in 1 through 3 above, was used for the 2001-
2002 NHANES dataset. 
5) Once the two separate datasets containing all variables of interest were checked and 
complete, variables that were the same but which had a slightly different variable 
name format were merged with a common name.  For example, the variable for the 
highest level of education was coded as “DMD140” in the 1999-2000 dataset and 
“DMDEDUC” in the 2001-2002 dataset.  The 1999-2000 dataset variable was 
renamed “DMDEDUC” to be consistent with the 2001-2002 variable name. 
6) Once the two datasets were combined, the frequencies were double-checked again 
against those published on the NHANES website. 
7) Once all variables were checked, the dataset was abridged to only women aged 16- 
49 years.   
Variables 
The NHANES collected demographic, questionnaire and laboratory data on 
approximately 5,000 people.  Markers and risk factors for CVD were all measured in the 
NHANES MEC.  Selected variables such as low density lipoprotein (LDL), triacylglycerols 
(TG), plasma glucose, dietary supplement intake, and total blood mercury were measured on 
only a sub-set of the NHANES population while others (e.g., hair mercury) were collected for 
only two of the four survey years.  The variable selection for the current analysis was restricted 






24-Hour Dietary Recall 
 
Data Availability in the NHANES (1999-2002) 
24-hour dietary records were collected by in-person interviews using a computer-
assisted dietary interview software program that was developed for the NHANES.  Charts and 
diagrams were provided to the respondents to aid accuracy of recall.  In the case of an 
incomplete dietary recall, the interviewers followed up with the respondent by telephone.  All 
survey participants were eligible for the dietary recall as translators and proxy reporting (parents 
or guardians) were both allowed.  Subjects were excluded only if cognitive difficulties 
prevented the dietary recall or if proxies were unavailable.  The dietary intakes of nutrients from 
reported foods were calculated using the USDA food and nutrient database version 1.0 for the 
2001 to 2002 dataset.  Nutrients were calculated in the 1999-2000 dataset using the USDA 
1994-1998 survey nutrient database.  The overall acceptability of each dietary recall was 
evaluated and assessed for reliability.  If less than 25% of the foods reported had missing 
descriptive information, less than 15% of the foods reported had missing amounts, or any meal 
reported did not have at least one identified food the recall data was labeled as unreliable.  A 
second day of diet recall was collected in the 2002 NHANES by telephone interview; however, 
these data were not released to the public because of confidentiality issues.   
 
Use of 24-Hour Dietary Recall Data in the Current Analysis 
Respondents with dietary recall data coded as unreliable were excluded from the current 





animal sources, a new variable was created to represent marine derived omega-3 fatty acids 
(DHA+EPA).  The variables for the omega-3 fatty acids DHA (20:5) and EPA (22:6) were 
summed to represent DHA + EPA from food sources and included as a single continuous 
variable in the final regression models. 
 
30-Day Fish Food Frequency Questionnaire 
Data Availability in the NHANES (1999-2002) 
The NHANES (1999-2002) provided a 30-day food frequency questionnaire (FFQ) for 
31 varieties of fish and shellfish.  Only children 1-5 years old and women 16-49 years old 
completed this questionnaire.   
Use of 30-Day Fish FFQ in the Current Analysis 
Total fish meals consumed over 30-days were determined by combining responses from 
each of the individual fish 30-day FFQ.  Total frequency of fish intake was not normally 
distributed.  Because it is count data, a square root transformation was applied to achieve 
normality.  The data for total frequency of fish consumed were split into four categories (none, 
1-4 times/30 days, 5-8 times/30 days, and 9+ times/30 days) to investigate the descriptive 
statistics.  These groupings were selected to match the AHA recommendations of eating fish 
twice weekly, which is approximately 8 times per month.  The square root of total frequency of 
fish consumption was included as a continuous independent variable in the regression models. 
 
Omega-3 Fatty Acid Dietary Supplements 
Dietary supplement use information was collected on a subset of NHANES participants.  





entire US population reported consuming a dietary supplement containing fish oil.  Based on 
these findings, fish oil supplementation was not included in the current analysis. 
Assessing omega-3 fatty acid and fish intake 
Researchers have used a variety of methods to assess intake of omega-3 fatty acids and 
fish.  Omega-3 fatty acid concentrations in both plasma and adipose tissue are good biomarkers 
of dietary omega-3 fatty acid intake (61, 62).  Anderson and colleagues (1999) found a slightly 
stronger correlation for DHA between dietary intake and plasma levels (r=0.52) compared to 
adipose tissue levels (r=0.49) (61).  However, adipose tissue levels more accurately reflect long-
term dietary intake (in the absence of recent weight loss) (63).  Plasma levels are a reliable 
measurement for recent (days to weeks) food intake (63) and are shown to be the most sensitive 
indicators of changes in polyunsaturated fatty acids.  Unfortunately plasma and adipose tissue 
measurements were not collected in NHANES (1999-2002). 
 
Mercury exposure 
Assessing Exposure to mercury 
Previous studies have used hair, toenail and whole blood to assess environmental 
exposure to Hg (2, 5, 35, 38, 40, 64, 65).  Hair Hg levels have been used historically as a 
biomarker of chronic exposure (36, 66); however hair Hg represents both environmental and 
dietary exposure to Hg.  Toenail Hg has not yet been established as a reliable biomarker; 
however, was used in multiple studies.  Toenail Hg has not yet been established as a reliable 
biomarker but has been used in multiple studies.  Measurements of total blood Hg levels may 
not capture long-term exposure to Hg as accurately as hair levels.  However, since the half-life 





intake from fish as indicated by the 30-day fish FFQ, and possibly the Hg exposure from fish 
consumed prior to this FFQ. 
 
Data Availability in the NHANES (1999-2002) 
 The NHANES 1999-2002 included measurements of blood, hair, and urine Hg (total and 
inorganic) for women of childbearing age (16-49 years of age) in an attempt to determine the 
exposure to Hg from fish.  Blood and hair measures were also included for children (1-5 years 
of age).  Hair Hg concentrations were obtained for the NHANES 1999-2000 only and were not 
included in the current study.  Toenail Hg was not measured in the NHANES.   
Total blood mercury:  Total Hg in whole blood was measured in the NHANES (1999-2002) 
using the methods described by T. Guo and J. Bassner (1).  Flow injection cold vapor atomic 
absorption analysis was conducted with on-line microwave digestion.    
Total hair mercury: The NCHS collected hair samples from women ages 16-49 and children 
ages 1-5.  A 3 cm segment of hair was removed from the occipital region of the scalp and used 
to characterize recent exposure to MeHg over a relatively uniform time interval (2.5 months).  
Approximately 100 mg (or 100 strands) of hair were collected from eligible participants.  
Details of the Hg analysis are described in McDowell et al, 2004.  Data on hair Hg are available 
only for the 1999-2000 NHANES dataset.     
Total urinary mercury:  Urinary Hg was measured in women (16-49 years of age) and 
children (1-5 years of age) in the NHANES 1999-2000.  Urinary Hg reflects exposure to 
inorganic Hg, which is not of interest in the current study.   





Because limited data on hair Hg concentrations were available, the current study used 
total blood Hg data as the dependent variable to represent exposure to MeHg from fish.  The 
Shapiro Wilk test was used to test for normality.  These data were log transformed to achieve 
normality. 
Risk markers of CHD 
Cholesterol (Total, HDL): 
Data Availability in the NHANES (1999-2002) 
Blood lipid profiles including TC and HDL were collected in NHANES (1999-2002) 
participants older than three years of age.  TC was determined enzymatically in serum or 
plasma.  The NHANES (1999-2002) documentation provides information on the laboratory 
assays and methodology used to measure blood lipids concentrations.    
Use of Blood Lipids Data in the Current Analysis 
 TC and HDL were both included as continuous dependent variables in separate 
regression analyses.  Both variables were normally distributed using the Shapiro Wilk test, so 
the data were not transformed. 
Triacylglycerol (TG) 
Data Availability in the NHANES (1999-2002) 
 Data for TG were available only for NHANES (1999-2002) participants aged 3 years 
and older who did not meet any exclusion criteria and who were examined in the morning 
sessions only (i.e. a sub-sample).  TG was measured enzymatically in serum or plasma using a 
series of coupled reactions (1).    





Despite the limited number of women for whom TG data were available; a separate 
regression analysis was performed to determine the relationship between fish consumption (30 
day fish FFQ) or DHA+EPA intake on TG.  This analysis was limited to 577 women with valid 
data for the variables of interest.   
LDL Cholesterol 
Data Availability in NHANES (1999-2002) 
LDL was calculated in NHANES (1999-2002) using the Friedewald calculation: 
[LDL cholesterol] = [TC] – [HDL cholesterol] – [TG/5] 
Because TG was measured for morning participants only, the calculations for LDL were limited 
to those participants with valid TG data.   
Use of LDL in the Current Study 
 Despite the limited number of women having calculated LDL data; a separate regression 
analysis was performed to determine the relationship between fish consumption (30 day fish 
FFQ) or DHA+EPA intake on LDL.  This analysis was limited to 577 women with valid data 
for the variables of interest.   
C-reactive protein 
 Data Availability in the NHANES (1999-2002) 
There are two methods of measuring CRP.  The newest technique is called high 
sensitivity CRP [(hs) CRP] and the second technique is simply called CRP.  According to the 





ranges from 0.5 -10 mg/L.  The non-high sensitivity CRP test (levels range from 10-1000 mg/L) 
is ordered for patients at risk for bacterial or viral infection (such as occurs following surgery) 
or for patients with chronic inflammatory.   
According to the NHANES (1999-2002) documentation, the NHANES researchers used 
latex-enhanced nephelometry with a Behring Nephelometer to quantitatively determine CRP 
concentrations.  CRP concentrations were calculated by using a calibration curve. 
  
Use of CRP in the Current Study 
The CRP data for women ages 16 to 49 were not normally distributed so a log 
transformation was needed to achieve normality.  CRP was treated as a continuous dependent 
variable in the multiple regression analyses. 
 
Reactive Oxygen Species 
Chronic and acute overproduction of reactive oxygen species (ROS) under 
pathophysiologic conditions is integral in the development of CHD.  The role of ROS in 
atherosclerosis has been demonstrated in animal models but clinical trials have not provided 
convincing evidence that antioxidants decrease the risks of CHD morbidity or mortality (67).  
This may be due to a lack of specific and sensitive biomarkers for assessing the oxidative stress 
phenotypes underlying CHD.  Additional research is necessary to identify reliable biomarkers of 
antioxidants and oxidative stress (67).   
Variables other than mercury and omega-3 fatty acids known to affect CHD 






Data Availability in the NHANES (1999-2002) 
Age and BMI were reported in the demographic portion of the NHANES (1999-2002).  
Age was reported in years for women aged 16-49 years and BMI was calculated as weight (kg) 
divided by height squared (m2).  NHANES participants were weighed and their standing height 
was measured in the MEC by trained technicians.   
 
Use of Age and BMI in the Current Study 
Age of subjects was stratified by decade for the regression models.  Women aged 16-19 
years were used as the reference population for comparisons between age groups.  BMI was 
included as a continuous variable in the regression models 2 and 3.   
 
Ethnicity and Education 
Data Availability in NHANES (1999-2002) 
 Self reported ethnicity and education were recorded in the NHANES.  There were five 
ethnicity categories including Non-Hispanic white, non-Hispanic black, Mexican American, 
Other Hispanic and Other.  The NHANES documentation indicated that “other” race includes 
multiracial, those with a single racial/ethnic identity other than the four listed above, those who 
reported more than one racial identity and those with missing values on race/ethnicity.  Level of 
education was coded as three categories:  less than high school or GED, high school or GED, 
more than high school.   
 
Use of Ethnicity and Education Variables in the Current Study 
To increase the sample size of each ethnic group, the “other Hispanic” and “other” 





reference population in the current study.   Ethnicity was included as an indicator variable in the 
regression analyses. 
Since a majority (40%) of subjects in the sample had an education level of “less than 
high school,” this group was used as the reference population for education.  The level of 
educational attainment was included as an indicator variable in the regression analyses.   
 
Diabetes, arthritis, and pregnancy 
Data Availability in the NHANES (1999-2002) 
Diabetes is known to increase the risk of CHD.  NHANES participants ages 12 and 
above provided measurements of plasma glucose, insulin, c-peptide and glycohemoglobin, and 
self-reported if a doctor had previously diagnosed them with diabetes (NHANES variable name, 
DIQ010).  The plasma glucose concentrations were measured on a sub-sample of the NHANES 
population.     
Arthritis increases inflammation and results in elevated CRP concentrations.  The 
presence of arthritis was listed as a current medical condition in the in-person questionnaire if 
respondents indicated that their “doctor ever said you had arthritis” (MCQ150A). 
Pregnancy testing was conducted using urine and blood specimens in women aged 12- 
59 years in the NHANES (1999-2002).  Initial urine tests were conducted and positive 
pregnancy tests were confirmed with serum pregnancy tests using the Icon 25 hCG 
(Urine/Serum) test kit.  This assay uses a combination of monoclonal and polyclonal antibodies 
to detect elevated levels of hCG in urine or serum, an indication of pregnancy (URXPREG).  
All samples were tested in the NHANES MEC.  In addition, females ages 12+ self-reported 






Use of Self-Reported Diabetic, Arthritic, and Pregnancy Variables in the Current Study 
Only 1,747 out of 4,084 women aged 16-49 years had valid plasma glucose data (prior to 
excluding women with missing data for other variables of interest). Therefore, the self reported 
diabetic status questionnaire response was used to identify persons with diagnosed diabetes.  
Participants with self-reported diabetic status (yes) were excluded from the analysis (n=104).  A 
sensitivity analysis was used to check if subjects who self-reported being non-diabetics actually 
had plasma glucose concentrations in the normal range.   
Only 227 of 1827 women with valid data indicated self-reported arthritis.  This variable 
was an insignificant explanatory variable when tested in three multiple regression models (CRP, 
HDL and TC), therefore, it was excluded from the final analysis.   
Self reported pregnancy status was used in the current analysis.  Of all women aged 16-
49 years, 674 reported being pregnant.  These women were excluded from the analyses. 
 
Medical history of coronary heart disease 
Data Availability in the NHANES (1999-2002) 
An in person cardiovascular disease questionnaire (CDQ_B) was used in the NHANES 
(1999-2002) to collect data on symptoms known to be associated with angina pectoris or 
respiratory disease.  The current physician-diagnosed medical conditions that subjects were 
asked to report included congestive heart failure (MCQ160B), coronary heart disease 
(MCQ160C), or angina (MCQ150D), or had a heart attack (MCQ160E), or stroke (MCQ160F).   
 
Use of Self Reported-Current Medical Condition Variables in the Current Study 
Because so few women (n=27) answered “yes” to the individual current medical 





“yes” to any of the above five conditions (congestive heart failure, coronary heart disease, 
angina, heart attack or stroke).  Self reported cardiovascular medical history was not a 
significant explanatory variable in any of the models (CRP, HDL, TC), and was excluded from 
the final regression models. 
 
Antioxidant intakes (vitamin C, vitamin E, and selenium) 
Data Availability in the NHANES (1999-2002) 
Antioxidant intake was extrapolated from the foods reportedly consumed in the 24-hour 
dietary recall interview.  Antioxidant levels in foods were determined by the National Centers 
for Health Statistics (NCHS) using the United States Department of Agriculture nutrient 
database (USDA/ARS, 2003).  Serum concentrations of vitamins A, E (AT), two retinyl esters 
and carotenoids were measured in NHANES using high performance liquid chromatography 
and multiwavelength detection.  However, antioxidant status in this analysis was based on food 
consumption reported in the 24-hour dietary recall, which may be a better estimate of daily 
nutrient intakes.  
 
Use of Antioxidant Intake Variables in the Current Study 
All antioxidants were included in the regression models as continuous independent 
variables.  
 
Aspirin and hypolipidemic prescription medications 





The prescription medication and medication sub-sample provides personal interview 
data on the use of these products during a one-month period prior to the survey date.  During the 
in-person interview, respondents either reported the name and duration of use of their 
prescription medication or dietary supplement, and if available, they provided the physical 
containers for these products.  The reporter entered the medication name into a database 
containing all prescription and non-prescription drug products available in the US (Master Drug 
Database, proprietary database of Facts and Comparison).  Each item was then identified as an 
“exact” or “most similar match,” or else it was designated as a “drug not found on list.”  All 
reported medication names were converted to their standard generic ingredient names (e.g. 
acetaminophen).   
 
Use of Prescription Medicine (Lipid Altering and Inflammation Altering) Variables in the 
Current Study 
An initial analysis was conducted to determine the prevalence of prescription medication 
use in the study sample.  1,108 of 2,209 women indicated taking prescription medication, but 
not all of the drugs taken affect markers of CHD or inflammation.  There was a significant 
positive association between prescription drug medication and all three dependent variables 
(CRP, HDL, TC).  Therefore, we used the Medline Plus for Drugs and Supplements database to 
look up each of the generic ingredients reported in the prescription medication questionnaire.  
Only drugs (hormones, antibiotics, anti-inflammatory and anti-virals) affecting lipid profiles 
were included in the analysis (see Appendix 1 and 2 for a listing of drug ingredients included).  





lipid or inflammatory altering ingredients.  The two separate prescription drug variables were 
included in regression models as categorical (indicator) variables.   
 
Hormones prescription medications 
Prescription drugs containing hormones were included in the inflammatory prescription 
drug variable.  785 of 2,209 women reported taking a prescription drug known to affect 
inflammation, which include drugs containing hormones.   
The NHANES questioned female participants (ages 12 years and older) in a private face-
to-face interview on reproductive health (RHQ_B).  The questionnaire contained questions on 
menstrual history, pregnancy history, lactation, oral contraceptive and hormone replacement 
therapy use, and other related conditions.   
Serum levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) were 
collected for women aged 35-60 years as well as questionnaire data on menstrual history to 
classify women according to menopausal status.  117 of 1,914 women aged 16-49 years with 
valid data for the current analysis were menopausal.  This variable for hormone concentrations 
was excluded from the final regression model since any hormones being ingested were included 
in the prescription medication portion of the analysis and age was a control variable.   
Exercise and physical activity 
Data Availability in the NHANES (1999-2002) 
The NHANES (2000-2001) included a physical activity questionnaire (PAQ) that asked 
questions related to daily- leisure-time- and sedentary-activities.  Respondents aged 16 years 
and older were asked these questions during the in-person household interview.  Some of the 





to vigorous activities (PAD200) but did not report any vigorous activities or reported a vigorous 
activity for less than a 10-minute duration were recoded as “no”.  A similar adjustment was 
done for moderate activities (PAD320).  Frequency of physical activities involving tasks and 
yard work (PAD120) and muscle strengthening activities (PAD460) were reported by the 
respondents on a daily, weekly, or monthly basis.  These data were then converted to a 30-day 
frequency.  Implausible responses (e.g. 12 hours or more per day) were recoded to “missing”.   
In addition to physical activity the survey assessed cardiovascular fitness by measuring 
maximal oxygen uptake (V02 Max testing).  This sub-max test was prescribed based on gender, 
age, BMI, and self-reported level of physical activity.  Participants were assigned to one of eight 
treadmill protocols.  The overall aim of the treadmill test was to elicit a heart rate approximately 
75 percent of the age predicted maximum (calculated by subtracting the age from 200) by the 
end of the test.  Each test included a two-minute warm-up, two 3-minute exercise stages, and a 
two-minute cool down.  Heart rate was monitored using an automated monitor with four 
electrodes connected to the subject (thorax and abdomen).  Blood pressure and perceived 
exertion (Borg Scale) were measured at the end of each exercise phase.   
The outcome variable of interest for this test (CVDESVO2) is the estimated maximal 
oxygen uptake (ml/kg/min).  This value was extrapolated using measured heart rate responses to 
known levels of exercise workloads, assuming the relation between heart rate and oxygen 
consumption is linear during exercise.  This concrete variable is less prone to self-reporting 
errors commonly seen in questions related to physical activity. 
 





Very few women aged 16-49 years (n=1,790) completed the required testing for 
estimated maximal oxygen uptake prior to excluding women who had missing data for other 
essential variables in the analysis (i.e. blood lipids, total blood mercury, fish FFQ).  This limited 
the sample for analysis by 50%, so self reported physical activity was used instead of VO2 max.  
Participants selected one of eight coded variables (see below) that best described their physical 
activity status.   
(0) Little or no regular recreation, sport or physical activity and avoids walking or exertion 
(1) Little or no regular recreation, sport or physical activity but walks for pleasure and occasionally exercise 
(2) Participating regularly in recreation or work requiring modes physical activity for 10 to 60 minutes per week.  
(3) Participating regularly in recreation or work requiring modest physical activity for more than 60 minutes per 
week.  
(4) Participating regularly in heavy physical activity for less than 30 minutes per week.  
(5) Participating regularly in heavy physical activity for 30-60 minutes per week.  
(6) Participating regularly in heavy physical activity for 1-3 hours per week.  
(7) Participating regularly in heavy physical activity for more than 3 hours per week.  
 
Since few participants reported exercise in the upper and lower ranges, we condensed 
the scale to three categories: “low,” “moderate,” and “high.”  Low included NHANES 
categories 0-1, “moderate” included categories 2-3 and “high” included categories 4-7.  The 
majority of subjects reported “moderate” physical activity.  The data were included in all 
regression models as a categorical variable, with “low” exercise as the reference population. 
 
Macronutrients (Carbohydrate, protein, fiber, fat, saturated fat, polyunsaturated fat, mono-
unsaturated fat, trans fat) 
Data Availability in the NHANES (1999-2002) 
Similar to the antioxidants mentioned earlier, energy, carbohydrate, dietary fiber, 
protein, and fat (monounsaturated, polyunsaturated, and saturated fatty acid) intakes were 
obtained from the foods reportedly consumed in the 24-hour recall data.  The nutrient content of 
foods was determined by the National Centers for Health Statistics (NCHS) using the United 





 The NHANES (1999-2002) did not separate out the varieties of dietary fiber.  Dietary 
fiber was reported as a single continuous variable derived from the 24-hour dietary recall 
interview and was included in the current study.  Along with fiber, the macro and micronutrients 
were included in all regression models as continuous variables.  However, because initial 
analyses revealed the existence of collinearity between most nutrients and the three dependent 
variables of interest (LDL, HDL, TC), only fiber, monounsaturated fat, and saturated fat were 
included in our regression models as potential confounding variables. 
 
Alcohol consumption 
Data Availability in the NHANES (1999-2002) 
  The   NHANES (1999-2002) obtained alcohol intake (including beer, wine, wine 
coolers and liquor) but excluded sips consumed for religious purposes.  Two questions were 
asked via Audio computer Assisted Personal Self Interview to respondents aged 12-19 years:  
1.  “During the past 30 days, on how many days did you have at least one drink of 
alcohol?”  Responses range from 0, 1-2, 3-5, 6-19, 20-29, all 30 days, refused, and don’t know. 
2.  “How many days did you have 5 or more drinks of alcohol in a row, that is, within a 
couple of hours.”  This question (ALQ.040) also addressed alcohol consumption during the past 
30 days. 
Information about alcohol consumption for adults aged 20+ also was recorded by 
Computer Assisted Personal interview (CAPI).  The NHANES variable ALQ.120 separated 
drinkers from non-drinkers in the past year.  ALQ.110 indicated whether or not the respondent 
ever consumed alcohol.  ALQ.120 asked how often the subject drank any type of alcoholic 
beverage “in the past 12 months”.  In addition to the CAPI, alcohol consumption was recorded 





Use of Alcohol Consumption in the Current Analysis 
All alcohol-containing beverages reported consumed in the 24-hour dietary recall 
interview were included in the regression analyses as a continuous variable.   
 
Smoking status 
Data Availability in NHANES (1999-2002) 
Environmental exposure to smoke can cause an increase in inflammation.  Tobacco use 
has been associated with multiple cancers as well as CHD among smokers (1).  The tobacco 
component of the NHANES included questionnaire items on current and past use of cigarettes, 
pipes, cigars, and smokeless tobacco.  It also addressed exposure to environmental tobacco 
smoke at home and work, as well as the use of nicotine replacement products (patch, gum).  
Cotinine (a metabolite of nicotine) was collected as a biochemical marker of exposure in 
participants ages 3 and older (1).   
 
Use of Smoking Status in the Current Analysis 
A review of the self-reported tobacco use questionnaire resulted in few (n=715) women 
who actually reported smoking at least 100 cigarettes per year, severely restricting the sample 
size for analysis.  Because smoking is known to be harmful to health, some women may be 
reluctant to admit to occasional smoking.  In addition, the self-reported smoking status will not 
identify women who are exposed to second hand smoke.  Serum cotinine status was used as a 
biomarker of nicotine exposure, which was collected for the majority of our sample of women 
aged 16-49 years.  In the current study, serum cotinine was included as a continuous control 






Univariate analyses and descriptive statistics were conducted on all variables to view the 
distribution of each variable as well as check the association of potential confounding variables 
with each dependent variable.  The distributions of continuous variables were tested for 
normality using the Shapiro Wilk test and supported by visual evaluation of histograms.  Data 
transformations were conducted, when necessary, to transform the variables to normality (the 
sum of 30-day fish food frequency (square root), CRP (log), and total blood Hg (log)).   
A small subset of women aged 16-49 years (n=211) were eliminated from the analysis 
sample due to missing four-year exam statistical weights.  Of the remaining women, data were 
statistically weighted using the four-year statistical weights (WTMEC4YR).  To correctly 
calculate the standard errors, the PSU (SDMVPSU) and Strata variables (SDMVSTRA) were 
used to account for the survey design effect of the NHANES (1999-2002).   
Means and standard errors were calculated using the survey commands in STATA for 
women ages 16-49 who were not pregnant, did not have diabetes (self reported) and had valid 
24-hour dietary recall data.  The mean of each continuous descriptive variable for the three 
categories of fish consumers (1-4 times per 30 days, 5-8 times per 30 days and > 9 times per 
thirty days) was compared to the mean for non-fish consumers using the accumulated Adjusted 
Wald Test.   
Outliers for total fish consumption were included in the analysis.  Sensitivity tests were 
conducted for all regression models excluding the outlier points (total fish frequency per 30 
days=118, total blood mercury= 4.0 ug/L).  This analysis did not produce significantly different 





A total of 10 separate multiple linear regression analyses were conducted (LDL, HDL, 
TC, TG and CRP each on both DHA+EPA and total frequency of fish consumption, separately).  
Each regression analysis was split into three tiers.  The first tier regressed blood lipids or CRP 
on total frequency of fish consumption or DHA + EPA controlling for only age (by decade) and 
BMI (continuous).  The second model controlled for all variables noted above including (age 
groups (20-29, 30-39, 40-49) BMI, self reported educational attainment, self reported ethnicity, 
self-reported physical activity, anti-inflammatory prescription drug use, lipid altering 
prescription drug use, serum cotinine, vitamin C, selenium, fiber, alcohol, mono-unsaturated 
fatty acids, saturated fatty acids).  Some of the continuous variables were re-coded into 
categorical variables to better understand the relationships between independent and dependent 
variables (age, DHA + EPA, total fish frequency consumption per 30 days).  Model 3 included 
total blood Hg (log) as a continuous variable.  The full model was used in each of the final 
results presentation. 
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Background:  Fish consumption has been shown to be inversely associated with coronary heart 
disease (CHD), which may be due to omega-3 fatty acids.  The omega-3 fatty acids, 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are naturally found only in 
marine sources.  Dietary intakes of methyl mercury from certain fish have been hypothesized to 
increase the risk of CHD. 
Objective:  Investigate the relationship between 30-day fish food frequency (FFQ), DHA+EPA 
intake, total blood mercury concentrations, and risk markers of CHD in women aged 16- 49 
years (NHANES 1999-2002). 
Design:  Multiple linear regressions were used to test 1) the relationships between 30-day fish 
FFQ and DHA+EPA intakes and five CHD risk markers: high density lipoprotein (HDL), low 
density lipoprotein (LDL) and total cholesterol (TC), triacylglycerol (TG), and C reactive 
protein (CRP) and 2) if total blood mercury attenuated any cardio-protective benefits. 
Results: Total 30-day FFQ was negatively associated with CRP (95% CI: -0.19 to -0.02, 
p=0.015) and positively associated with HDL (95% CI: 0.31 to 2.5, p=0.014).  Adjustment for 
other risk factors did not significantly attenuate the associations.  30-day fish FFQ and HDL 
were not significantly associated when total blood Hg was included in the model (95% CI: -0.60 
to 1.6, p<0.05) which was due to collinearity between fish intake and total blood mercury. 
Conclusions: Mercury concentrations in fish are not high enough to significantly impact CHD 





adequate to offset the hypothesized risks of ingesting mercury in fish.  Women can consume 
fatty fish in moderation as a part of a healthy diet. 






Fish and fish oils containing the omega-3 fatty acids docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) have been shown to have cardio-protective attributes in both 
healthy individuals and those at high risk of coronary heart disease (CHD) (68).  The chief 
dietary sources of DHA and EPA are fatty fish such as mackerel, lake trout, herring, tuna, 
sardines and salmon as well as dietary supplements.  Consumption of DHA and EPA and fish 
containing these fatty acids has been shown to reduce blood lipid concentrations of low density 
lipoprotein cholesterol (LDL), total cholesterol (TC) and triacylglycerol (TG) and to raise 
concentrations of high density lipoprotein cholesterol (HDL).  Omega-3 fatty acid intake is also 
associated with a reduction in plasma biomarkers of inflammation such as C-reactive protein 
(CRP) (28). The physiological effects of DHA and EPA include lowering plasma TG 
concentrations, inhibiting plaque formation, decreasing platelet aggregation and reducing 
arrhythmias (30). 
Fish also contains methyl mercury (MeHg), an environmental contaminant derived from 
industrial waste and the burning of fossil fuels.  MeHg makes its way into streams, lakes and 
oceans where it becomes incorporated into the food chain of marine animals (32).  There is 
evidence that MeHg may increase the risk of CHD by promoting the formation of free radicals 
and compromising the function of antioxidants that neutralize these agents (5).  Therefore, it is 
possible that consuming fish contaminated with MeHg may actually increase the risk of CHD.   
The hypothesis that MeHg attenuates the cardio-protective benefits of fish consumption 
remains unproven.  A review of seven epidemiological studies conducted to date (5 in men, 1 in 
women, and 1 with both men and women) suggests an association between MeHg exposure and 





specific role of MeHg on risk markers of CHD (3-6, 69).  The objective of the current study is to 
investigate relationships between 30-day frequency of fish intake, 24-hour DHA+EPA intake, 
total blood mercury (Hg) concentrations, and risk markers of CHD in women aged 16-49 years 
who participated in NHANES 1999-2002.  Indicators of CHD risk examined include blood 





Materials and Methods 
The NHANES (1999-2002) database was used to investigate relationships between fish 
consumption, dietary intake of marine omega-3 fatty acids (DHA+EPA), total blood Hg, and 
risk markers of CHD in women aged 16-49 years.  The NHANES is a stratified, multistage 
probability sample of the civilian non-institutionalized U.S. population which interviews 
approximately 5,000 people per survey year.  Respondents are interviewed in their homes and 
also complete a health examination component in mobile examination centers (MEC).  Low-
income persons, adolescents 12-19 years of age, people >60 years of age, African-Americans 
and Mexican-Americans are over-sampled (1). 
Independent Variables 
Fish intakes by women aged 16-49 years was assessed as the total number of fish meals 
reported consumed in a 30-day fish food frequency questionnaire (FFQ) in the NHANES (1999-
2002).  The NHANES participants did not provide data on the portion sizes of fish reported 
consumed in the fish FFQ.  In this analysis, total fish frequency of consumption data for women 
aged 16-49 years were grouped into four categories:  0, 1-4, 5-8, or > 9 times/30 days.  Shellfish 
were omitted from the analysis because they are low in Hg.  For individuals in each of the 4 fish 
consumption categories, mean blood lipids, CRP, total blood Hg, and nutrient concentrations 
along with descriptive statistics for selected demographic variables were calculated.  The 
summary statistics were derived using the 4-year statistical weights and adjusting for the 
statistical design of the survey as recommended by the NHANES analytic guidelines (1).    
Fish oil intake was calculated as the sum of DHA+EPA according to data derived from 





Fish oil consumption was included in the analysis as a secondary indicator of fish consumption 
for women aged 16-49 years. 
Dietary exposure to Hg was evaluated in this study using total blood Hg concentrations 
measured in NHANES (1999-2002) female participants aged 16-49 years.  
Dependent Variables 
The dependent variables of interest in this study were TC, HDL, and CRP.  Because TG 
data were available for a limited number of participants in the NHANES (1999-2002), a 
separate sensitivity analysis was conducted using serum TG and LDL concentrations. 
Covariate Variables 
Covariates were included in the regression models to take into account demographic, 
lifestyle, and nutritional factors.  Demographic and lifestyle variables were self-reported unless 
otherwise noted and included age (grouped for this analysis into 4 categories: 16-19, 20-29, 30-
39 and 40-49 years), ethnicity (non Hispanic white, non Hispanic black, Mexican American, 
other and other non-Hispanic), BMI (kg/m2, calculated by trained NCHS technicians), 
educational attainment (less than high school, high school or GED, or greater than high school), 
physical activity (separated into low, moderate and heavy levels of daily activity), prescription 
drug use (anti inflammatory or lipid lowering), serum cotinine concentrations (a measure of 
exposure to tobacco) and medical history of heart disease (physician- diagnosed diseases).  The 
diagnosis of heart disease was classified as congestive heart failure, coronary heart disease, 
angina, heart attack, or stroke.  Intake of individual nutrients was derived from the 24-hour 
dietary recall interview and was based on NCHS calculations.  Nutrient intakes (energy, fiber, 
monounsaturated fatty acids, saturated fatty acids, total cholesterol, vitamin C, alcohol and 





the models because they were not significantly associated with the dependent variables or 
caused collinearity included protein, carbohydrate, total fat, and total polyunsaturated fatty 
acids. 
Cohort for analysis  
The sample for this study was limited to women for whom data for the independent and 
dependent variables of interest were available.  The NHANES (1999-2002) dataset contains a 
total of 10,790 women, including 4,084 women aged 16-49 years.  Our sample was further 
restricted to women having measurements for total blood Hg (n=3,637), CRP (n=3,608), 24-
hour dietary recall interview (n=3,458), 30-day fish FFQ (n=3,456), TC (n=3,434), and HDL 
(n=3,435).  LDL and TG data were collected on only a subset of women, reducing the sample 
size to 1,726 prior to testing for confounding variables.   
Women were excluded from all analyses if they reported on the demographic 
questionnaire that they were pregnant (n = 704), if a doctor told them they were diabetic (n = 
104), or if their 24-hour dietary recall interview was coded by NCHS as unreliable  (n = 207).  
This occurred if >25% of foods reported consumed had missing descriptive information, >15% 
of foods had missing quantities eaten, or if a meal did not include at least one identified food.  In 
addition, 211 women who did not have 4-year statistical weights were excluded.  The numbers 
excluded are not mutually exclusive.  After these adjustments were made, the sample size was 
reduced to 1,245 women for the analysis of the major dependent variables, while 577 of the 
1,245 eligible women were included in the sensitivity analyses for LDL and TG. 
Statistical Methods 
STATA V. 7.0 (70) was used to conduct all statistical analyses including the univariate 
summaries and multiple regression models.  All estimates were derived using the 4-year MEC 





the survey regression commands in STATA.  The distributions of continuous variables were 
tested for normality using the Shapiro-Wilk test and data were transformed to achieve normality 
when necessary.  Prior to analysis, log transformations were done on CRP and total blood Hg 
values, and a square root transformation was performed on the total reported 30-day fish food 
frequency values. 
The following hypotheses were tested:  
(1) Fish intake is negatively associated with TC and CRP concentrations, and positively 
associated with HDL and total blood Hg concentrations  
(2) DHA+EPA intake is negatively associated with TC and CRP concentrations and 
positively associated with HDL and total blood Hg concentrations 
(3) Total blood Hg will attenuate the cardio-protective benefits demonstrated by fish and 
DHA+EPA consumption.   
The sample was stratified into categories defined by total frequency of fish consumption 
in the past 30 days (0, 1-4, 5-8, > 9 times/30 days).  Means of all continuous variables for each 
of the 3 fish-consuming groups were compared to the non-fish consuming group using the 
Adjusted Wald Test.   
The associations between total frequency of fish consumption in the past 30-days, blood 
lipids, and CRP concentrations were tested using multiple linear regression analyses.  The initial 
models (Model 1) adjusted for energy intake and age (separated by decade with women aged 16 
-19 years serving as the reference population).  To adjust for potential confounding, subsequent 
multivariate models included known CHD risk factors.   
Specifically, Model 2 adjusted for the variables in Model 1 as well as for lifestyle, 





prescription drug use (anti inflammatory or lipid lowering), ethnicity, educational attainment 
(indicator variables) and continuous variables such as BMI, smoking (measured as serum 
cotinine), and 24-hour dietary recall interview intakes of total calories, fiber, saturated fat, 
monounsaturated fat, vitamin C, selenium, and alcohol (continuous variables).   
Model 3 included total blood Hg concentrations (log) in addition to the variables 
included in Model 2.  The analyses were conducted separately for each of the blood lipids and 
CRP.  Similar analyses were conducted for the associations between 24-hour dietary intakes of 
DHA+EPA (replacing fish consumption frequency) and blood lipids and CRP.  Models 1 and 2 
provide data for testing for the first two hypotheses relating to the cardio-protective effects of 
fish consumption and DHA+EPA intake, while Model 3 addresses the third hypothesis (that 
total blood Hg will attenuate the potential protective effect of fish consumption tested for the 
first two models).  The sample for all multiple linear regression analyses was limited to women 
aged 16-49 years with valid data for all variables included in Model 3 (n=1,245). 
Results 
Characteristics of the population 
Demographic and lifestyle characteristics, nutrient intake, and blood biomarkers of CHD 
risk by fish consumption category are summarized in Tables 1-3.  The 1,245 non-pregnant 
women that constitute this study sample had an average age of 32.5 + 0.4 years and an average 
BMI of 26.3 + 0.22 kg/m2.  The reported average daily caloric intake of the sample was slightly 
less than 2,000 calories/day (1993.6 + 25.5 kcals/day).  The study sample reported an average of 
2.9+ 0.13 fish meals over 30 days (less than one fish meal per week), and had an average intake 
of 0.1 + 0.01 g DHA+ EPA calculated from the 24-hour dietary recall interview, confirming a 
low fish intake. 
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The majority of the sample of women aged 16-49 years consumed fish 1-4 times/30 
days.  When separated by ethnicity the majority of all race/ethnicity groups were split between 
non-fish consumers and consuming fish 1-4 times/30 days.  Study participants who classified 
themselves as “other Hispanic” and “other” had the greatest percentage of regular fish 
consumers (fish > 9 times/30 days) (10%).  The majority of Mexican Americans were non-fish 
consumers (43%) and light (1-4 times/30 days) fish consumers (48%). 
Regular fish consumers (>9 times/30 days) had the lowest serum cotinine levels than all 
of the other fish and non-fish consuming groups.  Fish consumers had significantly lower serum 
cotinine levels than non-fish consumers (p=0.0043), suggesting that fish consumers are less 
likely to smoke and to be exposed to second hand smoke (Table 1).  Reported fish consumption 
patterns were similar between the three physical activity groups.  The majority of women in all 
physical activity groups were non-fish consumers (26-29%) and light fish consumers (1-4 
times/30 days) (52-56%).  All nutrient intakes analyzed were significantly higher in each of the 
fish consuming groups as compared to the non-fish consumers (p<0.05) with the exception of 
carbohydrate, saturated fat, alcohol, and vitamin C (Table 2). 
Average daily DHA+EPA intake for fish consumers was significantly greater than non-
fish consumers (p<0.00001).  Regular fish consumers’ (> 9 times/30 days) DHA + EPA intakes 
were more than double (0.46+ 0.11 g/day) the DHA+EPA intakes of both the frequent (0.18+ 
0.04 g/day) and infrequent fish consumers (0.07+ 0.01g/day). 
Of the blood lipids tested, HDL concentrations were higher in the fish consumption 
groups compared to the non fish consumers (p=0.0011), while no differences existed across 
groups for any of the other lipids or CRP (Table 3).  The women in this sample had desirable 





average CRP was 0.36 + 0.02 mg/L, below the value of 1 mg/L which indicates inflammation 
(16).   
Total blood Hg concentrations increased gradually for each fish consumption group, 
with fish consumers having significantly greater concentrations than non-fish consumers 
(p<0.00001) (Table 3).  Regular fish consumers (> 9 times/30 days) had a seven-fold greater 
total blood Hg concentration than non-fish consumers (4.2 + 0.7 ug/L vs. 0.6 + 0.05 ug/L). 
Fish Consumption, Lipid Profile and CRP 
Initial analyses adjusting for age and energy demonstrated significant negative 
associations between total 30-day frequency of fish consumption and CRP concentrations (95% 
CI: -0.19 to -0.02, p=0.015) and significant positive associations with HDL concentrations (95% 
CI: 0.31 to 2.5, p=0.014).  After adjustments for known risk factors for CHD (BMI, educational 
attainment, ethnicity, self reported physical activity, self reported use of anti inflammatory or 
lipid lowering prescription drugs, serum cotinine, vitamin C, selenium, fiber, alcohol, mono-
unsaturated fatty acids and saturated fatty acids) there were not any changes in the associations 
between 30-day frequency of fish consumption and CRP, and HDL concentrations (Table 4).  
Total 30-day frequency of fish consumption was negatively associated with TC in all models 
(p>0.05). 
Sensitivity analyses conducted on the subset of women aged 16-49 years with measured 
data for TG (n=577) demonstrated that after adjustment for age and other known CHD risk 
factors, 30-day frequency of fish consumption was negatively associated with TG 
concentrations (95% CI: -8.0 to -0.33, p=0.034) and calculated LDL concentrations (p>0.05) 
(Table 4). 
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The calculated 24-hour dietary intake of DHA+EPA was not associated with 
concentrations of CRP or the blood lipids HDL and TC (data not provided).  However, 
DHA+EPA was negatively associated with LDL concentrations (95% CI: -12.9 to -0.04, 
p=0.049) after adjustment for age and other known CHD risk factors but DHA+EPA was no 
longer significantly associated with LDL concentrations after the addition of total blood Hg to 
the model (95% CI: -13.1 to 0.24, p=0.06). 
Fish Consumption, Blood Lipids, CRP and Total Blood Mercury  
The association between total blood Hg concentrations (log transformed values) and 
demographic variables was analyzed using multiple linear regressions (Table 5).  Women in the 
30-39 years and 40-49 years age categories had significantly greater total blood Hg 
concentrations than women aged 16-19 years (p<0.05).  Compared to the other race/ethnicity 
groups, non-Hispanic blacks had significantly greater total blood Hg concentrations (95% CI: 
0.14 to 0.58, p=0.002).  After adjusting for age, energy, BMI, education, ethnicity, physical 
activity, prescription drug use (anti inflammatory or lipid lowering), serum cotinine, vitamin C, 
selenium, fiber, alcohol, mono-unsaturated fatty acids, and saturated fatty acids, total blood Hg 
concentrations were significantly higher in all fish consumption groups compared to the non fish 
eaters, indicating a high correlation between fish intake and total blood Hg concentrations.   
The addition of total blood Hg (log) in the Model 3 regression analyses showed 
attenuation of the association between total 30-day frequency of fish consumption and HDL 
concentrations to non-significant levels (95% CI: -0.60 to 1.6, p=0.372).  To test this attenuation 
effect we calculated the mean HDL concentration for each group of fish consumers separated by 
tertile of total blood mercury concentration (Table 6). This analysis showed an increasing trend 
in HDL cholesterol with increasing tertile of mercury intake demonstrating the high collinearity 





The addition of total blood Hg (log) in Model 3 for CRP did not cause appreciable 
changes in the association with CRP concentrations (95% CI: -0.18  -0.03, p=0.010) (Table 4).  
Similar to the analysis conducted with HDL, the average CRP concentration was calculated by 
fish consumption group and tertile of total blood mercury concentration.  The average CRP 
concentrations were similar for the different fish frequency consumption groups (data not 
shown) as well as for fish versus non-fish consumers and increased with each tertile of total 
blood Hg (Table 7). 
Addition of total blood mercury (log) in Model 3 for the relationship between total 
frequency of fish consumption and TG resulted in a non-significant association between total 
frequency of fish and TG concentrations (95% CI: -6.0 to 1.44, p=0.183).  A follow up analysis 
to test this affect (i.e calculated average TG by tertile of total blood Hg and fish consumption 
category) showed a decrease in TG for each tertile of total blood Hg, again demonstrating the 
high collinearity between fish consumption and total blood Hg concentrations (data not shown).     
Discussion 
The results of this study suggest an association between frequent fish intake and selected 
risk markers of CHD (HDL, TG, and CRP) in women aged 16-49 years.  As the total 30-day 
frequency of fish consumption increased, concentrations of HDL increased while concentrations 
of TG and CRP decreased.  The beneficial effects of fish on HDL concentrations were not 
diminished as total blood Hg concentrations became elevated.  The presence of Hg in blood had 
less impact on CRP levels.  Further analyses of the effects of total blood Hg on HDL and CRP 
by fish consumption group indicated that there was strong collinearity between fish 





of fish consumption.  No significant associations were seen between fish intake and either LDL 
or TC concentrations.  
The positive effects of fish intake on HDL concentrations and incidence of CHD have 
been reported in both men and women (4, 27, 71).  The results of this study support previous 
findings that fish consumption does not consistently affect TC concentrations (4, 7, 72). 
Organic (methyl) Hg is present in fish due to its uptake from environmental sources (32).  
In humans, the sole source of exposure to organic Hg is the consumption of fish and sea 
mammals (33).  Research has linked Hg ingestion from fish to increased risk of CHD in men (2-
5, 7).  In our study of women aged 16-49 years, total blood Hg seemed to diminish the positive 
associations between 30-day frequency of fish consumption and HDL concentrations; however 
further analyses on this effect demonstrated that it was due to collinearity between fish 
consumption and total blood Hg.  Attenuations in risk of CHD due to Hg exposure were 
reported in studies including men (2-5, 7).  However, inconsistent relationships between 
biomarkers of Hg and CHD risk have been reported, perhaps due to differences in the ages of 
the study subjects, frequency of fish consumption among populations studied (i.e. Americans eat 
less fish than Finns), type of fish consumed, and health status of the study samples (6-8).       
Our further analysis showed that fish consumers had higher mean HDL concentrations in 
every tertile of total blood Hg, suggesting that total blood Hg concentrations do not abate the 
benefits of fish consumption.  Total blood Hg concentrations also did not affect the relationship 
between total 30-day frequency of fish consumption and CRP.  It is possible that MeHg does not 
affect inflammation or that concentrations of Hg in fish are not high enough to significantly 





fish consumption group demonstrated the high correlation between fish consumption and total 
blood Hg, thus CRP concentrations increased with tertile of total blood Hg.   
A small study conducted in 10 healthy individuals showed that an induced low-dose Hg 
exposure caused by the removal of dental amalgams resulted in significant plasma Hg 
concentrations 24-hours post amalgam removal.  However, there was no significant effect of Hg 
on CRP concentrations up to 7 days post-removal (73).  In a follow-up study, 1 g of pulverized 
amalgam powder was administered to 11 healthy adults.  This low dose exposure to MeHg 
caused significant increases in blood Hg concentrations but did not result in any significant 
changes in plasma CRP concentrations.  MeHg may not affect CHD risk with respect to 
inflammatory mechanisms such as CRP (74).  
CRP is a predictor of CHD risk (11) and is affected by numerous lifestyle variables.  In 
general, individuals with elevated CRP concentrations tend to smoke, have high blood pressure, 
are overweight, and fail to exercise (13).  A few studies have evaluated the effects of dietary 
intakes of DHA+EPA on CRP concentrations and other biomarkers of inflammation in different 
samples of subjects and have produced varying results (21, 55).  The calculated 24-hour dietary 
intakes of DHA+EPA in our study were not associated with CRP concentrations.   
DHA+EPA have been shown to positively affect HDL and TG concentrations.  Men and 
women supplemented with 2.8 g/day DHA had an 8% increase in HDL, a 28% decrease in TG, 
and no significant changes in LDL or TC concentrations (55).  DHA and EPA may be cardio-
protective by lowering plasma concentrations of TG (30, 75).  Our sensitivity analysis 
conducted on 577 women showed protective effects when 30-day frequency of fish 
consumption was used as the independent variable and TG as the dependent variable.  The 





other studies.  Our results agree with other studies, which have shown that fish intake or 
markers of fish intake (plasma PUFA) do not significantly impact LDL or TC levels (4, 7).  The 
24-hour calculated DHA+EPA intake in our study was also less than the AHA recommendation 
(at least 0.5-1.0 g of omega-3 fatty acids per day to achieve cardio-protective effects) which 
may explain the lack of association in the models where HDL, LDL, TC were the independent 
variables (76).  When 24-hour dietary intake of DHA+EPA was used as a marker of fish 
consumption there were no cardio-protective effects in risk markers of CHD.  The lack of 
association is most likely because DHA+EPA intakes were calculated by NCHS based upon 24-
hour dietary recall data, from which fish intake is variable.  One-day dietary intake records do 
not represent average long-term consumption especially in foods such as fish that are not 
commonly consumed. 
This cross sectional study extends the results of previous studies using the NHANES 
dataset (1999-2000).  The average total blood Hg (log) was higher for the 1,245 women (aged 
16 to 49 years) in the current study than Hg levels reported from the same dataset using a 
different sample of 1,709 women (1.6 vs. 1.02 ug Hg/L ) (38).  Schober et al, (2003) also 
reported that women who ate 3 or more servings of fish (in the past 30 days) had four fold 
greater geometric mean Hg concentrations compared with non fish consuming women (38).  A 
second study that analyzed hair Hg data reported a three fold higher hair Hg concentrations in 
frequent fish consumers (> 3 times in the past 30-days) than in non-fish consumers (65).  In the 
current study, there was a seven fold difference between women who consumed fish > 9 
times/30 days and the non-fish consumers.  The differences between studies are most likely due 





 When total blood Hg data were analyzed by race/ethnicity, the results of the current 
study are consistent with two recent reports that analyzed relationships between calculated 
organic blood Hg (rather than total blood Hg concentrations), hair Hg concentrations, and fish 
intake during the first two years of the NHANES (1999-2000) (64, 65).  The lowest blood 
organic MeHg concentrations were in Mexican Americans and the highest concentrations were 
in participants who designated themselves in the “other” racial/ethnic category, which included 
Asians, Native Americans, and Pacific Islanders (64).  Mahaffey reported that women aged 30-
49 years has blood organic mercury concentrations 1.5 times greater than women aged 16-29 
years.  Similarly, we found a two-fold difference in total blood mercury concentrations between 
women aged 16-19 and 30-39 years (1.0 + 0.1 vs. 2.0+0.3 ug/L).  
Only 57 women in our sample reported consuming fish >9 times in the past 30 days, a 
frequency similar to the AHA recommendation of eating fish at least twice a week.  Most of the 
women were either non-fish consumers (n=441) or light fish consumers (1-4 times/30 days, 
n=166), and thus failed to meet the AHA guideline for fish.    
Self-reported exercise may not accurately reflect the participant’s true physical activity 
levels.  The fish consumption patterns were approximately the same for each of the 3 physical 
activity groups analyzed. 
Concerns about organic Hg exposure have focused on its negative impacts on the 
neurodevelopment of infants and young children.  Mercury data on other populations and data 
derived from large surveys are lacking.  Our study was limited to a sub-sample of women ages 
16 to 49 years in the NHANES (1999-2002) dataset for who total blood Hg data were available.  
Therefore, these results cannot be generalized to other population groups.  Inherent to a large 





sectional study we cannot exclude the possibility that the cardio-protective effects of fish and 
DHA+EPA and the effect of total blood Hg on HDL may be due to un-measured variables.  
However, we included commonly analyzed variables that are available in the NHANES public 
release data and are known to affect risk of CHD. 
Omega-6 and omega-3 PUFAs compete during metabolism and an excessive intake of 
omega-6 fatty acids may attenuate the cardio-protective benefits normally seen with omega-3 
PUFAs.  In a large prospective cohort study, Mozaffarian et al (2005) investigated the joint 
effects of different PUFAs on the risk of CHD in men.  These researchers saw benefits in the 
combination of plant and marine based omega-3 PUFAs on CHD risk independent of omega-6 
PUFA consumption.  They concluded that non-marine based omega-3 PUFAs are beneficial in 
reducing risk of CHD, especially when populations do not have easy access or availability to 
marine sources (77).  The interplay of plant derived omega-3 fatty acids were not analyzed in 
the current study 
Finally, the results of this study would have been strengthened if data on LDL and TG 
were available for more subjects, since both of these lipid biomarkers may be affected by 
omega-3 fatty acids (33).  However, the analysis on a subpopulation did not show any 
association between omega-3-fatty acids and these blood lipids. Other inflammatory biomarkers 
such as Interleukin-6, or other cytokines may be better indicators of CHD risk than CRP, but 
these data were not available in the current NHANES surveys. 
The current study included two measures of fish intake, a 30-day frequency of fish 
intake and a second 24-hour dietary recall interview that assessed DHA+EPA intake.  The 30-
day fish FFQ provides a good estimate of habitual dietary patterns that may reveal the potential 





dietary recall data for a food that is not regularly consumed by the study subjects.  Another 
strength is that the current study included healthy women of childbearing age, whereas studies 
that examined the joint association between fish intake, methyl mercury and CHD only included 
men and older women.  Finally, because the NHANES dataset is large, we were able to control 
for a number of demographic and lifestyle variables. 
Summary 
The results of this study provide further support for recommending regular fish 
consumption along with maintaining a healthy lifestyle (e.g., not smoking and getting daily 
moderate exercise) as a way of reducing the risk of CHD.  The effect of mercury on biomarkers 
of inflammation is unclear.  Based on this study and others, it appears that the levels of mercury 
in fish are not high enough to significantly impact the risk of CHD in healthy women of 
childbearing age.  Furthermore, the levels of omega-3 fatty acids in fish may be adequate to 
offset the risks of ingesting mercury in fish.  Future studies using the NHANES (1999-2000) 30-
day fish food frequency questionnaire should separately analyze the relationships between fatty 
fish intake and total fish intake on health-related variables.  Further research is also needed to 















5 to 8 times / 30
days 
(n= 131) 
Fish Consumers  




Age (y) 28.9 + 0.6 33.5 + 0.5 35.4 + 1.2 33.9 + 1.5 <0.00001
BMI (kg/m2) 26.0 + 0.6 26.6 + 0.3 25.8 + 0.6 26.9 + 0.9 NS
Ethnicity (%) 
  Mexican American  43.2 48.0 6.4 2.4
  Non-Hispanic white 26.7 54.0 14.2 5.1
  Non-Hispanic black 24.4 51.8 16.3 7.5
  Other Hispanic and Other 26.2 53.0 10.5 10.3
Serum cotinine (ng/mL) 46.1 + 6.8 46.8 + 6.8 39.7 + 6.7 15.0 + 6.2 0.0043
Physical activity readiness code (%) 
    Little or no exercise 1,2 29.4 54.5 11.3 4.8
    Moderate exercise 3,4 26.3 52.0 15.4 6.3
    Heavy exercise 5-8 28.1 55.7 10.3 5.9
Summaries presented as Mean + SEM for the continuous variables and percentage in each category for the categorical variables 
1  Adjusted Wald Test to test the accumulated difference of all fish consumers versus non- fish consumers 
2  Little or no regular recreation, sport or physical activity and avoids walking or exertion 
3  Little or no regular recreation, sport or physical activity but walks for pleasure and occasionally exercise 
4  Participating regularly in recreation or work requiring modes physical activity for 10 to 60 minutes per week.  
5  Participating regularly in recreation or work requiring modest physical activity for more than 60 minutes per week.  
6  Participating regularly in heavy physical activity for less than 30 minutes per week.  
7  Participating regularly in heavy physical activity for 30-60 minutes per week.  
8  Participating regularly in heavy physical activity for 1-3 hours per week.  











 1 to 4 times / 30 
days 
 (n=616) 
Fish Consumers  








Kcals (kcal/day) 1918 + 42.2 1975 + 36.1 2110 + 78.3 2252 + 122.1 0.028
Protein (g/day) 65.1 + 2.0 68.6 + 1.4 79.3 + 4.3 86.7 + 4.4 0.0003
Carbohydrate (g/day) 254.5 + 6.0 251.7 + 5.6 266.1 + 9.1 267.7 + 20.4 NS23
Fiber (g/day) 12.9 + 0.5 13.9 + 0.5 14.6 + 0.8 16.1 + 1.2 0.0451
Fat (g/day) 69.5 + 2.3 74.9 + 1.6 78.8 + 4.6 89.2 + 5.3 0.020
Saturated fatty acids (g/day) 23.3 + 0.9 24.8 + 0.6 25.4 + 1.4 27.8 + 2.3 NS
Monounsaturated fatty acids (g/day) 26.3 + 0.95 28.0 + 0.6 28.9 + 1.8 33.5 + 1.9 0.042
Polyunsaturated fatty acids (g/day)  14.0 + 0.6 15.4 + 0.5 16.7 + 1.1 19.7 + 1.6 0.007
Alcohol intake (g/day) 6.0 + 1.2 7.6 + 1.2 7.9 + 1.5 10.6 + 3.8 NS
Cholesterol (g/day) 217.9 + 12.0 223.6 + 8.4 280.4 + 21.9 299.8 + 24.7 0.042
Vitamin C (mg/day) 83.7 + 7.1 79.1 + 3.9 92.9 + 7.8 104.1 + 18.1 NS
Selenium (mcg/day) 83.8 + 2.9 91.6 + 2.4 108 + 6.1 121.3 + 8.8 0.0002
DHA + EPA (g/day) 0.03 + 0.01 0.07 + 0.01 0.18 + 0.04 0.46 + 0.11 <0.00001
1 Nutrients calculated by NHANES from the 24-hour dietary recall interview 
2  Adjusted Wald Test to test the accumulated difference of all fish consumers versus non- fish consumers  





Table 3.  Blood lipids, C-reactive protein and total blood mercury concentrations by fish consumption group  (Mean + SEM) 












Consumers 5 to 




Fish Consumers  





Total cholesterol (mg/dL) 184.9 + 2.6 190.6 + 1.4 185.5 + 4.5 191.9 + 3.4 NS6
HDL cholesterol (mg/dL) 52.2 + 1.2 57.1 + 0.9 55.6 + 1.2 59.5 + 2.0 0.0011
LDL cholesterol (mg/dL) 111.4 + 3.7 109.6 + 1.9 108.9 + 5.2 114.6 + 3.9 NS
Triacylglycerol (mg/dL) 101.3 + 5.0 104.2 + 3.5 109.5 + 13.7 95.8 + 10.4 NS
CRP (mg/L) 0.35 + 0.03 0.39 + 0.03 0.27 + 0.04 0.30 + 0.08 NS
Total blood mercury (ug/L) 0.6 + 0.05 1.6 + 0.1 2.2 + 0.3 4.2 + 0.7 <0.00001
1n=195 for LDL, and n=213 for Triacylglycerol 
2n=288 for LDL, and n=304 for Triacylglycerol 
3n=64 for LDL, and n=67 for Triacylglycerol 
4n=30 for LDL, and n=32 for Triacylglycerol 
5 Adjusted Wald Test to test the accumulated difference of all fish consumers versus non- fish consumers 








Table 4.  Summaries of regressions of CHD risk factors on 30-day fish frequency consumption 
(g/person/day), women aged 16 to 49 years NHANES 1999-2002 
Dependent Variable Sample Size Model R2 
Square root of fish 
frequency  
b (95% CI) P 
C Reactive protein       
     Model 1 1 1245 0.04 -0.1 (-0.19  -0.02) 0.015 
     Model 2 2 1245 0.33 -0.09 (-0.15  -0.02) 0.011 
     Model 3 3 1245 0.33 -0.10 (-0.18  -0.03) 0.010 
HDL cholesterol       
     Model 1 1 1245 0.04 1.4 (0.31  2.5) 0.014 
     Model 2 2 1245 0.25 1.0 (0.07  2.0) 0.036 
     Model 3 3 1245 0.25 0.48 (-0.60  1.6) NS 
Total cholesterol       
     Model 1 1 1245 0.12 -1.4 (-3.2  0.36) NS 
     Model 2 2 1245 0.15 -0.80 ( -2.7  1.1) NS 
     Model 3 3 1245 0.15 -1.7 (-4.5  1.1) NS 
LDL cholesterol     
     Model 1 1 577 0.07 -2.1 (-5.1  0.84) NS 
     Model 2 2 577 0.13 -1.8 (-4.8  1.2) NS 
     Model 3 3 577 0.13 -2.1 (-5.3  1.1) NS 
Triacylglycerol       
     Model 1 1 577 0.02 -4.4 (-8.7  -0.02) 0.049 
     Model 2 2 577 0.14 -4.2 (-8.0  -0.33) 0.034 
     Model 3 3 577 0.14 -2.3 (-5.9  1.2) NS 
1 Adjusted for age and energy  
2 Adjusted for Model 1 variables, BMI, education, ethnicity, physical activity, prescription drug use (anti 
inflammatory or lipid lowering), serum cotinine, vitamin C, selenium, fiber, alcohol, mono-unsaturated fatty acids, 
saturated fatty acids  
3 Adjusted for model 2, log total blood mercury (log), and the interaction term of total blood mercury (log)*square 





Table 5.  Regression model for y=log (total blood Hg)1, Women aged 16 to 49 years 





Age Group      
  16 to 19 years -   0.91 + 0.1  
  20 to 29 years 0.22 (-0.05 to 0.48) 1.3 + 0.1 0.103
  30 to 39 years 0.48 (0.22 to 0.73) 1.8 + 0.2 0.001
  40 to 49 years 0.65 (0.34 to 0.96) 1.8 + 0.2 <0.0001
Race/Ethnicity    
  Non-Hispanic white -  1.5 + 0.1  
  Non-Hispanic black 0.36 (0.14 to 0.58) 1.7 + 0.2 0.002 
  Mexican American 0.10 (-0.06 to 0.26) 1.2 + 0.1 0.201 
  Other Hispanic and other 0.31 (-0.03 to 0.65) 2.0 + 0.4 0.075 
Fish consumption frequency in past 30 days   
  0 -  0.62 + 0.05  
  1 to 4 times 0.83 (0.63 to 1.03) 1.6 + 0.1 <0.0001 
  5 to 8 times 1.17 (0.89 to 1.45) 2.2 + 0.3 <0.0001 
  9 + times 1.76 (1.41 to 2.1) 4.2 + 0.7 <0.0001 
1 Adjusted for age, energy, BMI, education, ethnicity, physical activity, prescription drug use 
(anti inflammatory or lipid lowering), serum cotinine, vitamin C, selenium, fiber, alcohol, 
mono-unsaturated fatty acids, saturated fatty acids 





Table 6.  Average HDL concentration by total blood Hg tertile and fish versus non fish 
consumers (mg/L), women aged 16 to 49 years NHANES 1999-2002 
Fish Group   Total Blood Hg Tertile 
    1 2 3 Total
Mean 51.5 54.1 50.4 52.2Non fish  
consumers 95% CI 48.8 to 54.1 48.9 to 59.3 48.0 to 52.7  
Mean 52.5 56.6 59.6 57.0
Fish consumers 95% CI 50.0 to 55.1 54.6 to 58.6 57.2 to 62.0   







Table 7.  Average CRP concentration by total blood Hg tertile and fish versus non fish 
consumers (mg/dL), women aged 16 to 49 years NHANES 1999-2002 
Fish Group   Total Blood Hg Tertile 
    1 2 3 Total
Mean 0.14 0.17 0.14 0.15Non fish  
consumers 95% CI 0.11 to 0.17 0.14 to 0.2 0.07 to 0.25  
Mean 0.17 0.13 0.15 0.15
Fish consumers 95% CI 0.14 to 0.2 0.11 to 0.15 0.12 to 0.18  
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Chapter 4:  Implications and Future Research  
Health implications 
Fish intake of at least two servings per week is beneficial for maintaining desirable 
blood lipid profiles and markers of inflammation and was also associated with an overall 
healthier lifestyle (lower exposure to smoking, lowest number of non-exercisers, greatest intake 
of various nutrients known to be beneficial such as fiber, mono-unsaturated fat, DHA+EPA, 
vitamin C and selenium).  Our research showed that people in the two highest fish consuming 
categories had the lowest CRP concentrations compared to non-fish and light fish consumers 
despite intervention data not showing significant differences.  Our findings agree with other 
published observational data and provide further support for the AHA fish consumption 
recommendations.   
In addition to supporting the AHA fish recommendations, the results of this 
observational study are consistent with other observational research findings on the 
cardiovascular benefits of fish consumption, specifically on CHD risk markers.  Despite the 
contamination of many varieties of fish, the limited sample of female fish consumers of 
childbearing age in the US had desirable blood lipid profiles.  The current research shows that 
despite both the risks and benefits of fish consumption, moderate fish intakes will result in 
increased HDL and reduced TG concentrations, thus may reduce the risk of CHD.  People 
interested in these effects may begin to incorporate fatty fish known to have lower or limited 
mercury concentrations into a balanced diet; however maintain awareness of fish known to have 





Consumers in the US are often provided with cautionary statements regarding fish and 
the contaminants often found in fish, including PCBs and mercury.  The current research my be 
included with future observational and intervention studies which may find that the mercury 
concentrations in fish do not outweigh the benefits of fish consumption, resulting in reduced 
fear of fish consumption by the US population and increased fish intakes. 
Importance of the research 
The results of our study imply that the concentrations of Hg in blood are not yet great 
enough to abate the cardio-protective benefits of fish consumption in women aged 16-49 years; 
however, additional research on high CHD risk populations may show different results.  Starting 
in 2002, the NHANES began collecting blood mercury data on the sample population aged >1 
year.  These measurements will provide a reference point for the women of childbearing age 
from which results of further studies on the joint effects of DHA+EPA and mercury can be 
compared.  Our study provides a basis for preliminary comparison for these future studies.   
Additional research is necessary to understand if there exists a threshold concentration 
where the risks of certain fish outweigh the benefits.  The lack of strong association between Hg 
and the CHD risk markers may imply that the concentrations of Hg in our food supply are not 
great enough to cause concern for cardiovascular health and that consumers at greater risk for 
CHD are better off eating fish for the beneficial properties (high protein, low fat, rich in 
antioxidants and omega-3 fatty acids) rather than selecting foods that may not have these 
beneficial attributes.  On the other hand, the weak association between Hg and the CHD risk 
markers may have been attributed to the younger age of our population group which is not 





demonstrating the benefits of fish consumption; despite the mixed findings in intervention 
studies.  Additional clinical and intervention research is necessary to better understand the role 
of fish consumption, omega-3 fatty acid intake and Hg intake on CHD risk.     
Suggestions for further research 
Three studies have been published using data from the first two years of the NHANES 
data (38, 64, 65).  Ideas for future research would be to replicate these studies using the 1999-
2002 dataset.  In addition the NHANES 1999-2002 data could be used to determine how many 
women have total blood Hg concentrations greater than 5.8 ug/L and if these women with >5.8 
ug/L total blood Hg also have high reported fish consumption?  If not, researchers should 
review other NHANES data (food intake records, dental history) for the possible reason for 
these elevated Hg concentrations.     
In addition to a high total blood Hg analysis, further studies could be conducted to 
investigate any possible relationships between specific varieties of fish and the overall health 
profiles of consumers (especially dark fatty fish known to be excellent sources of omega-3 fatty 
acids as well as fish known to be high in mercury).  Examples of research questions to 
investigate include: (1) Do significant differences exist between the risk markers of CHD in 
non-tuna consumers, light tuna consumers and heavy tuna consumers?  and (2) do populations at 
the highest risk for CHD not report consuming fish? 
Our research also showed that the group composed of other Hispanic and other 
ethnicities had the greatest measured total blood mercury concentrations.  A future evaluation of 
the diet, lipid biomarkers and CHD risk markers of this population group may provide more 





associated with fish consumption in this race/ethnicity group may reveal healthy food 
consumption habits also associated with decreased CHD risk.  
The lack of findings in the DHA+EPA regression model speaks to the need for longer-
term dietary intake data.  Precision in estimating dietary intake data is necessary for policy 
makers and public health professionals to best understand what the US population is consuming.  
Future releases of NHANES data will incorporate a second day of dietary data, which is 
essential to capture the intakes of foods not commonly consumed, such as fish.  When 
researchers, public health and policy professionals use nationally representative food intake data 
to estimate exposure to foods, nutrients, or contaminants in foods or nutrients, from foods that 
are not regularly consumed (e.g. fish), the result will underestimate the actual population 
exposure and may result in unnecessary cautionary statements due to lack of better data. 
Even for those consumers who reported fish twice weekly, mean DHA+EPA intakes in 
our study were still below the AHA 1 g/day recommendations (0.46 + 0.11 g/day).  This may 
indicate that the women who reported eating fish did not eat dark fatty fish or other fish known 
to contain the healthy omega-3 fatty acids.  Clinical studies have failed to show significant 
associations between omega-3 fatty acids (both plant and marine based) and inflammatory 
markers (78-80); however, observational studies have shown otherwise (25, 81).  Further 
research is needed to better understand the anti-inflammatory effects of fish consumption and if 
any effects are due to omega-3 fatty acids or a combination of nutrients found in fish or dietary 
patterns associated with fish intake, not just omega-3 fatty acids.  
There exists research on the effects of consumer awareness of state and local sport-fish 
advisories and fish consumption.  It is possible that the currently available consumer advisories 





specific to fish type, the public that is already bombarded with conflicting nutritional 
information may be generalizing the health concerns of Hg and other chemically contaminated 
fish varieties to all fish.  Continued consumer awareness studies need to be conducted with the 





Appendix 1:  List of lipid altering drug ingredients 
Lipid Altering Standard Generic Ingredient Name FDA Drug Class Code 
ALUMINUM CHLORIDE 411
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE 506
AMLODIPINE BESYLATE 3570










































Appendix 2:  List of anti-inflammatory drug ingredients 




ACETAMINOPHEN; CODEINE PHOSPHATE 36120
ACETAMINOPHEN; DICHLORALANTIPYRINE; ISOMETHEPTENE 
MUCATE (1:1) 7016
ACETAMINOPHEN; HYDROCODONE BITARTRATE 55040
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE 30960
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE 1720
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE 27520




ALBUTEROL SULFATE; IPRATROPIUM BROMIDE 3880
AMMONIUM LACTATE 1265
AMOXICILLIN 15224
AMOXICILLIN TRIHYDRATE; CLAVULANATE POTASSIUM 2422
AMPICILLIN 1038
ASPIRIN 3440
ASPIRIN; BUTALBITAL; CAFFEINE 1044
ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE 
TEREPHTHALATE 3440





BENZOYL PEROXIDE; ERYTHROMYCIN 1265
BIRTH CONTROL DRUG-UNSPECIFIED 3120



























DESOGESTREL; ETHINYL ESTRADIOL 16544












ESTRADIOL; NORETHINDRONE ACETATE 1034
ESTROGENS, CONJUGATED SYNTHETIC A 1034




ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE 6204
ETHINYL ESTRADIOL; LEVONORGESTREL 35156
ETHINYL ESTRADIOL; NORETHINDRONE 25850
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 14560
ETHINYL ESTRADIOL; NORGESTIMATE 66176









FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE 1940
GRISEOFULVIN, MICROCRYSTALLINE 358
GUAIFENESIN 1940







































PENICILLIN G PROCAINE 346
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